Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Paul A Bunn

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone303/724-4498

    Collapse Research 
    Collapse research activities and funding
    T32CA009331     (KANE, MADELEINE A)Sep 1, 1981 - Jun 30, 1997
    NIH/NCI
    POSTGRADUATE TRAINING IN CANCER RESEARCH
    Role: Co-Principal Investigator

    P30CA046934     (THEODORESCU, DAN)Mar 1, 1988 - Jan 31, 2022
    NIH/NCI
    University of Colorado Cancer Center Support Grant
    Role: Co-Principal Investigator

    C06CA054080     (BUNN, PAUL A)Mar 1, 1991 - May 31, 1992
    NIH/NCI
    EXTRAMURAL RESEARCH FACILITIES CONTRUCTION
    Role: Principal Investigator

    P50CA058187     (BUNN, PAUL A.)Sep 30, 1992 - Apr 30, 2019
    NIH/NCI
    SPORE in Lung Cancer
    Role: Principal Investigator

    R13CA062871     (BUNN, PAUL A)Sep 15, 1993 - Sep 14, 1995
    NIH/NCI
    COLORADO LEADERSHIP SUMMIT
    Role: Principal Investigator

    R13CA064509     (BUNN, PAUL A)Jun 17, 1994 - Jun 16, 1995
    NIH/NCI
    7TH WORLD CONFERENCE ON LUNG CANCER
    Role: Principal Investigator

    R13CA074443     (BUNN, PAUL A)Sep 30, 1996 - Sep 29, 1998
    NIH/NCI
    COLORADO BLUEPRINT--WOMEN/MINORITIES CANCER CARE TRIAL
    Role: Principal Investigator

    C06CA091516     (BUNN, PAUL A)Sep 22, 2000 - Jun 30, 2004
    NIH/NCI
    EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION
    Role: Principal Investigator

    U56CA110039     (BUNN, PAUL A)Jun 1, 2004 - May 31, 2006
    NIH/NCI
    UC4 AP4 Cancer Therapy Center
    Role: Principal Investigator

    RC2CA148394     (BUNN, PAUL A.)Sep 29, 2009 - Aug 31, 2012
    NIH/NCI
    Lung Cancer Mutation Analysis
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Tang ZZ, Bunn P, Tao R, Liu Z, Lin DY. PreMeta: a tool to facilitate meta-analysis of rare-variant associations. BMC Genomics. 2017 Feb 14; 18(1):160. PMID: 28196472.
      View in: PubMed
    2. He Y, Bunn PA, Zhou C, Chan D. KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer. Oncotarget. 2016 Dec 13; 7(50):82104-82111. PMID: 27893413.
      View in: PubMed
    3. Paz-Ares LG, Zimmermann A, Ciuleanu T, Bunn PA, Antonio BS, Denne J, Iturria N, John W, Scagliotti GV. Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer. Lung Cancer. 2017 Feb; 104:45-51. PMID: 28212999.
      View in: PubMed
    4. Bunn PA. Karnofsky Award 2016: A Lung Cancer Journey, 1973 to 2016. J Clin Oncol. 2017 Jan 10; 35(2):243-252. PMID: 28056194.
      View in: PubMed
    5. Scarborough HA, Helfrich BA, Casás-Selves M, Schuller AG, Grosskurth SE, Kim J, Tan AC, Chan DC, Zhang Z, Zaberezhnyy V, Bunn PA, DeGregori J. AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition. Clin Cancer Res. 2017 Mar 15; 23(6):1531-1541. PMID: 27663586.
      View in: PubMed
    6. Suda K, Bunn PA, Rivard CJ, Mitsudomi T, Hirsch FR. Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench. J Thorac Oncol. 2017 Jan; 12(1):27-35. PMID: 27642065.
      View in: PubMed
    7. Hirsch FR, Suda K, Wiens J, Bunn PA. New and emerging targeted treatments in advanced non-small-cell lung cancer. Lancet. 2016 Sep 03; 388(10048):1012-24. PMID: 27598681.
      View in: PubMed
    8. Langer CJ, Obasaju C, Bunn P, Bonomi P, Gandara D, Hirsch FR, Kim ES, Natale RB, Novello S, Paz-Ares L, Pérol M, Reck M, Ramalingam SS, Reynolds CH, Socinski MA, Spigel DR, Wakelee H, Mayo C, Thatcher N. Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment. J Thorac Oncol. 2016 Dec; 11(12):2066-2081. PMID: 27575423.
      View in: PubMed
    9. Helfrich BA, Kim J, Gao D, Chan DC, Zhang Z, Tan AC, Bunn PA. Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo. Mol Cancer Ther. 2016 Oct; 15(10):2314-2322. PMID: 27496133.
      View in: PubMed
    10. Socinski MA, Obasaju C, Gandara D, Hirsch FR, Bonomi P, Bunn P, Kim ES, Langer CJ, Natale RB, Novello S, Paz-Ares L, Pérol M, Reck M, Ramalingam SS, Reynolds CH, Spigel DR, Stinchcombe TE, Wakelee H, Mayo C, Thatcher N. Clinicopathologic Features of Advanced Squamous NSCLC. J Thorac Oncol. 2016 Sep; 11(9):1411-22. PMID: 27296106.
      View in: PubMed
    11. Tan DS, Yom SS, Tsao MS, Pass HI, Kelly K, Peled N, Yung RC, Wistuba II, Yatabe Y, Unger M, Mack PC, Wynes MW, Mitsudomi T, Weder W, Yankelevitz D, Herbst RS, Gandara DR, Carbone DP, Bunn PA, Mok TS, Hirsch FR. The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016. J Thorac Oncol. 2016 Jul; 11(7):946-63. PMID: 27229180.
      View in: PubMed
    12. Patil T, Aisner DL, Noonan SA, Bunn PA, Purcell WT, Carr LL, Camidge DR, Doebele RC. Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status. Lung Cancer. 2016 Jun; 96:27-32. PMID: 27133746.
      View in: PubMed
    13. Tsao AS, Scagliotti GV, Bunn PA, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan AU, McWilliams A, Tsao MS, Adusumilli PS, Rami-Porta R, Asamura H, Van Schil PE, Darling GE, Ramalingam SS, Gomez DR, Rosenzweig KE, Zimmermann S, Peters S, Ignatius Ou SH, Reungwetwattana T, Jänne PA, Mok TS, Wakelee HA, Pirker R, Mazières J, Brahmer JR, Zhou Y, Herbst RS, Papadimitrakopoulou VA, Redman MW, Wynes MW, Gandara DR, Kelly RJ, Hirsch FR, Pass HI. Scientific Advances in Lung Cancer 2015. J Thorac Oncol. 2016 May; 11(5):613-38. PMID: 27013409.
      View in: PubMed
    14. Bunn PA, Gaspar LE, Weyant MJ, Mitchell JD. Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer. Cancer. 2016 Mar 01; 122(5):674-5. PMID: 26700372.
      View in: PubMed
    15. Steuer CE, Behera M, Berry L, Kim S, Rossi M, Sica G, Owonikoko TK, Johnson BE, Kris MG, Bunn PA, Khuri FR, Garon EB, Ramalingam SS. Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium. Cancer. 2016 Mar 01; 122(5):766-72. PMID: 26695526.
      View in: PubMed
    16. Hirsch FR, Bunn PA. Adjuvant TKIs in NSCLC: what can we learn from RADIANT? Nat Rev Clin Oncol. 2015 Dec; 12(12):689-90. PMID: 26552954.
      View in: PubMed
    17. Merrick DT, Gao D, Miller YE, Keith RL, Baron AE, Feser W, Kennedy TC, Blatchford PJ, Braudrick S, Hirsch FR, Heasley L, Bunn PA, Franklin WA. Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma. Cancer Prev Res (Phila). 2016 Jan; 9(1):96-104. PMID: 26542061.
      View in: PubMed
    18. Levy BP, Chioda MD, Herndon D, Longshore JW, Mohamed M, Ou SH, Reynolds C, Singh J, Wistuba II, Bunn PA, Hirsch FR. Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations. Oncologist. 2015 Oct; 20(10):1175-81. PMID: 26330460.
      View in: PubMed
    19. Sholl LM, Aisner DL, Varella-Garcia M, Berry LD, Dias-Santagata D, Wistuba II, Chen H, Fujimoto J, Kugler K, Franklin WA, Iafrate AJ, Ladanyi M, Kris MG, Johnson BE, Bunn PA, Minna JD, Kwiatkowski DJ. Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience. J Thorac Oncol. 2015 May; 10(5):768-77. PMID: 25738220.
      View in: PubMed
    20. Bunn PA, Kim ES. Improving the Care of Patients With Stage IB Non-Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers. Clin Lung Cancer. 2015 Jul; 16(4):245-51. PMID: 25887065.
      View in: PubMed
    21. Pekar-Zlotin M, Hirsch FR, Soussan-Gutman L, Ilouze M, Dvir A, Boyle T, Wynes M, Miller VA, Lipson D, Palmer GA, Ali SM, Dekel S, Brenner R, Bunn PA, Peled N. Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer. Oncologist. 2015 Mar; 20(3):316-22. PMID: 25721120.
      View in: PubMed
    22. Morgensztern D, Campo MJ, Dahlberg SE, Doebele RC, Garon E, Gerber DE, Goldberg SB, Hammerman PS, Heist RS, Hensing T, Horn L, Ramalingam SS, Rudin CM, Salgia R, Sequist LV, Shaw AT, Simon GR, Somaiah N, Spigel DR, Wrangle J, Johnson D, Herbst RS, Bunn P, Govindan R. Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol. 2015 Jan; 10(1 Suppl 1):S1-63. PMID: 25535693.
      View in: PubMed
    23. Scarborough HA, Bunn PA, DeGregori J. Personalized one-two punches for lung cancer. Cell Res. 2015 Mar; 25(3):269-70. PMID: 25547118.
      View in: PubMed
    24. Iyengar P, Kavanagh BD, Wardak Z, Smith I, Ahn C, Gerber DE, Dowell J, Hughes R, Abdulrahman R, Camidge DR, Gaspar LE, Doebele RC, Bunn PA, Choy H, Timmerman R. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. J Clin Oncol. 2014 Dec 01; 32(34):3824-30. PMID: 25349291.
      View in: PubMed
    25. Villaruz LC, Socinski MA, Abberbock S, Berry LD, Johnson BE, Kwiatkowski DJ, Iafrate AJ, Varella-Garcia M, Franklin WA, Camidge DR, Sequist LV, Haura EB, Ladanyi M, Kurland BF, Kugler K, Minna JD, Bunn PA, Kris MG. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Cancer. 2015 Feb 01; 121(3):448-56. PMID: 25273224.
      View in: PubMed
    26. Johnson DH, Schiller JH, Bunn PA. Reply to A. Braillon. J Clin Oncol. 2014 Nov 01; 32(31):3575. PMID: 25225428.
      View in: PubMed
    27. Hirsch FR, Bunn PA, Herbst RS. "Companion diagnostics": has their time come and gone? Clin Cancer Res. 2014 Sep 01; 20(17):4422-4. PMID: 25059519.
      View in: PubMed
    28. Kris MG, Johnson BE, Berry LD, Kwiatkowski DJ, Iafrate AJ, Wistuba II, Varella-Garcia M, Franklin WA, Aronson SL, Su PF, Shyr Y, Camidge DR, Sequist LV, Glisson BS, Khuri FR, Garon EB, Pao W, Rudin C, Schiller J, Haura EB, Socinski M, Shirai K, Chen H, Giaccone G, Ladanyi M, Kugler K, Minna JD, Bunn PA. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014 May 21; 311(19):1998-2006. PMID: 24846037.
      View in: PubMed
    29. Wynes MW, Hinz TK, Gao D, Martini M, Marek LA, Ware KE, Edwards MG, Böhm D, Perner S, Helfrich BA, Dziadziuszko R, Jassem J, Wojtylak S, Sejda A, Gozgit JM, Bunn PA, Camidge DR, Tan AC, Hirsch FR, Heasley LE. FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies. Clin Cancer Res. 2014 Jun 15; 20(12):3299-309. PMID: 24771645.
      View in: PubMed
    30. Bunn PA, Hirsch FR, Aisner DL. Is there clinical value to prognostic signatures in early-stage NSCLC? Clin Cancer Res. 2014 Apr 01; 20(7):1727-9. PMID: 24583801.
      View in: PubMed
    31. Johnson DH, Schiller JH, Bunn PA. Recent clinical advances in lung cancer management. J Clin Oncol. 2014 Apr 01; 32(10):973-82. PMID: 24567433.
      View in: PubMed
    32. Stieglitz Ham H, Bunn P, Meyer C, Khan A, Hickson L. Exploring the relationship between technology use, hearing help-seeking, and hearing aid outcomes in older adults. Int J Audiol. 2014 Feb; 53 Suppl 1:S38-42. PMID: 24400825.
      View in: PubMed
    33. Hirsch FR, Bunn PA. Progress in research on screening and genetics in lung cancer. Lancet Respir Med. 2014 Jan; 2(1):19-21. PMID: 24461890.
      View in: PubMed
    34. Davies KD, Mahale S, Astling DP, Aisner DL, Le AT, Hinz TK, Vaishnavi A, Bunn PA, Heasley LE, Tan AC, Camidge DR, Varella-Garcia M, Doebele RC. Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer. PLoS One. 2013; 8(12):e82236. PMID: 24349229.
      View in: PubMed
    35. Bunn PA, Franklin W, Doebele RC. The evolution of tumor classification: a role for genomics? Cancer Cell. 2013 Dec 09; 24(6):693-4. PMID: 24332038.
      View in: PubMed
    36. Peled N, Zach L, Liran O, Ilouze M, Bunn PA, Hirsch FR. Effective crizotinib schedule for brain metastases in ALK rearrangement metastatic non-small-cell lung cancer. J Thorac Oncol. 2013 Dec; 8(12):e112-3. PMID: 24389447.
      View in: PubMed
    37. Weickhardt AJ, Doebele RC, Purcell WT, Bunn PA, Oton AB, Rothman MS, Wierman ME, Mok T, Popat S, Bauman J, Nieva J, Novello S, Ou SH, Camidge DR. Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients. Cancer. 2013 Jul 01; 119(13):2383-90. PMID: 23585220.
      View in: PubMed
    38. Ohashi K, Sequist LV, Arcila ME, Lovly CM, Chen X, Rudin CM, Moran T, Camidge DR, Vnencak-Jones CL, Berry L, Pan Y, Sasaki H, Engelman JA, Garon EB, Dubinett SM, Franklin WA, Riely GJ, Sos ML, Kris MG, Dias-Santagata D, Ladanyi M, Bunn PA, Pao W. Characteristics of lung cancers harboring NRAS mutations. Clin Cancer Res. 2013 May 01; 19(9):2584-91. PMID: 23515407.
      View in: PubMed
    39. Peled N, Barash O, Tisch U, Ionescu R, Broza YY, Ilouze M, Mattei J, Bunn PA, Hirsch FR, Haick H. Volatile fingerprints of cancer specific genetic mutations. Nanomedicine. 2013 Aug; 9(6):758-66. PMID: 23428987.
      View in: PubMed
    40. Shepherd FA, Bunn PA, Paz-Ares L. Lung cancer in 2013: state of the art therapy for metastatic disease. Am Soc Clin Oncol Educ Book. 2013; 339-46. PMID: 23714542.
      View in: PubMed
    41. Mascaux C, Feser WJ, Lewis MT, Barón AE, Coldren CD, Merrick DT, Kennedy TC, Eckelberger JI, Rozeboom LM, Franklin WA, Minna JD, Bunn PA, Miller YE, Keith RL, Hirsch FR. Endobronchial miRNAs as biomarkers in lung cancer chemoprevention. Cancer Prev Res (Phila). 2013 Feb; 6(2):100-8. PMID: 23268837.
      View in: PubMed
    42. Bunn PA. Worldwide overview of the current status of lung cancer diagnosis and treatment. Arch Pathol Lab Med. 2012 Dec; 136(12):1478-81. PMID: 23194039.
      View in: PubMed
    43. Weickhardt AJ, Scheier B, Burke JM, Gan G, Lu X, Bunn PA, Aisner DL, Gaspar LE, Kavanagh BD, Doebele RC, Camidge DR. Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(12):1807-14. PMID: 23154552.
      View in: PubMed
    44. Raben D, Bunn PA. Biologically targeted therapies plus chemotherapy plus radiotherapy in stage III non-small-cell lung cancer: a case of the Icarus syndrome? J Clin Oncol. 2012 Nov 10; 30(32):3909-12. PMID: 23045597.
      View in: PubMed
    45. Peled N, Hakim M, Bunn PA, Miller YE, Kennedy TC, Mattei J, Mitchell JD, Hirsch FR, Haick H. Non-invasive breath analysis of pulmonary nodules. J Thorac Oncol. 2012 Oct; 7(10):1528-33. PMID: 22929969.
      View in: PubMed
    46. Casás-Selves M, Kim J, Zhang Z, Helfrich BA, Gao D, Porter CC, Scarborough HA, Bunn PA, Chan DC, Tan AC, DeGregori J. Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition. Cancer Res. 2012 Aug 15; 72(16):4154-64. PMID: 22738915.
      View in: PubMed
    47. Witta SE, Jotte RM, Konduri K, Neubauer MA, Spira AI, Ruxer RL, Varella-Garcia M, Bunn PA, Hirsch FR. Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy. J Clin Oncol. 2012 Jun 20; 30(18):2248-55. PMID: 22508830.
      View in: PubMed
    48. Hirsch FR, Bunn PA. A new generation of EGFR tyrosine-kinase inhibitors in NSCLC. Lancet Oncol. 2012 May; 13(5):442-3. PMID: 22452893.
      View in: PubMed
    49. Doebele RC, Lu X, Sumey C, Maxson DA, Weickhardt AJ, Oton AB, Bunn PA, Barón AE, Franklin WA, Aisner DL, Varella-Garcia M, Camidge DR. Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer. Cancer. 2012 Sep 15; 118(18):4502-11. PMID: 22282022.
      View in: PubMed
    50. Barash O, Peled N, Tisch U, Bunn PA, Hirsch FR, Haick H. Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine. 2012 Jul; 8(5):580-9. PMID: 22033081.
      View in: PubMed
    51. Hirsch FR, Kabbinavar F, Eisen T, Martins R, Schnell FM, Dziadziuszko R, Richardson K, Richardson F, Wacker B, Sternberg DW, Rusk J, Franklin WA, Varella-Garcia M, Bunn PA, Camidge R, Camidge DR. A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer. J Clin Oncol. 2011 Sep 10; 29(26):3567-73. PMID: 21825259.
      View in: PubMed
    52. Keith RL, Blatchford PJ, Kittelson J, Minna JD, Kelly K, Massion PP, Franklin WA, Mao J, Wilson DO, Merrick DT, Hirsch FR, Kennedy TC, Bunn PA, Geraci MW, Miller YE. Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prev Res (Phila). 2011 Jun; 4(6):793-802. PMID: 21636546.
      View in: PubMed
    53. Bunn PA, Doebele RC. Genetic testing for lung cancer: reflex versus clinical selection. J Clin Oncol. 2011 May 20; 29(15):1943-5. PMID: 21483017.
      View in: PubMed
    54. Rafnar T, Sulem P, Besenbacher S, Gudbjartsson DF, Zanon C, Gudmundsson J, Stacey SN, Kostic JP, Thorgeirsson TE, Thorleifsson G, Bjarnason H, Skuladottir H, Gudbjartsson T, Isaksson HJ, Isla D, Murillo L, García-Prats MD, Panadero A, Aben KK, Vermeulen SH, van der Heijden HF, Feser WJ, Miller YE, Bunn PA, Kong A, Wolf HJ, Franklin WA, Mayordomo JI, Kiemeney LA, Jonsson S, Thorsteinsdottir U, Stefansson K. Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk. Cancer Res. 2011 Feb 15; 71(4):1356-61. PMID: 21303977.
      View in: PubMed
    55. Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD, Helfrich BA, Garrett-Mayer E, Bunn PA, Drabkin HA. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 2011 Jan 01; 300(1):66-78. PMID: 20980099.
      View in: PubMed
    56. Hirsch FR, Wynes MW, Gandara DR, Bunn PA. The tissue is the issue: personalized medicine for non-small cell lung cancer. Clin Cancer Res. 2010 Oct 15; 16(20):4909-11. PMID: 20926402.
      View in: PubMed
    57. Bunn PA, Pacheco T. Lessons learned from the systematic evaluation of cutaneous T-cell lymphomas at the national cancer institute and the roadmap for future studies. Clin Lymphoma Myeloma Leuk. 2010 Sep; 10 Suppl 2:S74-9. PMID: 20826402.
      View in: PubMed
    58. Hirsch FR, Mok TS, Borges V, Bunn PA. Molecularly targeted therapy: when to stop and when to continue? Lancet Oncol. 2010 Aug; 11(8):709-11. PMID: 20570560.
      View in: PubMed
    59. Bunn PA, Hirsch FR, Doebele RC, Camidge DR, Varella-Garcia M, Franklin W. Biomarkers are here to stay for clinical research and standard care. J Thorac Oncol. 2010 Aug; 5(8):1113-5. PMID: 20661083.
      View in: PubMed
    60. Dziadziuszko R, Merrick DT, Witta SE, Mendoza AD, Szostakiewicz B, Szymanowska A, Rzyman W, Dziadziuszko K, Jassem J, Bunn PA, Varella-Garcia M, Hirsch FR. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. J Clin Oncol. 2010 May 01; 28(13):2174-80. PMID: 20351332.
      View in: PubMed
    61. Pisters KM, Vallières E, Crowley JJ, Franklin WA, Bunn PA, Ginsberg RJ, Putnam JB, Chansky K, Gandara D. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol. 2010 Apr 10; 28(11):1843-9. PMID: 20231678.
      View in: PubMed
    62. Bunn PA. Optimal therapy for elderly patients with early stage non-small cell lung cancer. Am J Respir Crit Care Med. 2010 Feb 01; 181(3):201-2. PMID: 20093653.
      View in: PubMed
    63. Doebele RC, Oton AB, Peled N, Camidge DR, Bunn PA. New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer. Lung Cancer. 2010 Jul; 69(1):1-12. PMID: 20092908.
      View in: PubMed
    64. Camidge R, Gaspar L, Goss G, Kelly K, Ramalingam S, Reckamp K, Simon G, Tsao M, West HJ, Herbst R, Johnson D, Bunn P, Govindan R. Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium. J Thorac Oncol. 2009 Jul; 4(7):930-5. PMID: 19550249.
      View in: PubMed
    65. Hickinson DM, Marshall GB, Beran GJ, Varella-Garcia M, Mills EA, South MC, Cassidy AM, Acheson KL, McWalter G, McCormack RM, Bunn PA, French T, Graham A, Holloway BR, Hirsch FR, Speake G. Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib. Clin Transl Sci. 2009 Jun; 2(3):183-92. PMID: 20443891.
      View in: PubMed
    66. Hirsch FR, Bunn PA. EGFR testing in lung cancer is ready for prime time. Lancet Oncol. 2009 May; 10(5):432-3. PMID: 19410185.
      View in: PubMed
    67. Dadds MR, Hawes DJ, Frost AD, Vassallo S, Bunn P, Hunter K, Merz S. Learning to 'talk the talk: the relationship of psychopathic traits to deficits in empathy across childhood. J Child Psychol Psychiatry. 2009 May; 50(5):599-606. PMID: 19445007.
      View in: PubMed
    68. Kelly K, Kittelson J, Franklin WA, Kennedy TC, Klein CE, Keith RL, Dempsey EC, Lewis M, Jackson MK, Hirsch FR, Bunn PA, Miller YE. A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer. Cancer Prev Res (Phila). 2009 May; 2(5):440-9. PMID: 19401528.
      View in: PubMed
    69. Varella-Garcia M, Mitsudomi T, Yatabe Y, Kosaka T, Nakajima E, Xavier AC, Skokan M, Zeng C, Franklin WA, Bunn PA, Hirsch FR. EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort. J Thorac Oncol. 2009 Mar; 4(3):318-25. PMID: 19247083.
      View in: PubMed
    70. Bunn PA. Novel therapies for non-small-cell lung cancer: a 2008 update. Clin Lung Cancer. 2009 Mar; 10 Suppl 1:S6. PMID: 19362947.
      View in: PubMed
    71. Witta SE, Dziadziuszko R, Yoshida K, Hedman K, Varella-Garcia M, Bunn PA, Hirsch FR. ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC). Ann Oncol. 2009 Apr; 20(4):689-95. PMID: 19150934.
      View in: PubMed
    72. Gera L, Chan DC, Simkeviciene V, Bunn PA, Stewart JM. N-(Fluorenyl-9-methoxycarbonyl)amino acid amide derivatives as a new class of anti-cancer agents. Adv Exp Med Biol. 2009; 611:465-6. PMID: 19400267.
      View in: PubMed
    73. Peled N, Oton AB, Hirsch FR, Bunn P. MAGE A3 antigen-specific cancer immunotherapeutic. Immunotherapy. 2009 Jan; 1(1):19-25. PMID: 20635969.
      View in: PubMed
    74. Marek L, Ware KE, Fritzsche A, Hercule P, Helton WR, Smith JE, McDermott LA, Coldren CD, Nemenoff RA, Merrick DT, Helfrich BA, Bunn PA, Heasley LE. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells. Mol Pharmacol. 2009 Jan; 75(1):196-207. PMID: 18849352.
      View in: PubMed
    75. Hirsch FR, Varella-Garcia M, Dziadziuszko R, Xiao Y, Gajapathy S, Skokan M, Lin M, O'Neill V, Bunn PA. Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer. Clin Cancer Res. 2008 Oct 01; 14(19):6317-23. PMID: 18829515.
      View in: PubMed
    76. Hirsch FR, Herbst RS, Olsen C, Chansky K, Crowley J, Kelly K, Franklin WA, Bunn PA, Varella-Garcia M, Gandara DR. Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy. J Clin Oncol. 2008 Jul 10; 26(20):3351-7. PMID: 18612151.
      View in: PubMed
    77. Hirsch FR, Dziadziuszko R, Varella-Garcia M, Franklin WA, Gandara DR, Bunn PA. First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay. J Thorac Oncol. 2008 Jun; 3(6 Suppl 2):S138-42. PMID: 18520298.
      View in: PubMed
    78. Einhorn LH, Bonomi P, Bunn PA, Camidge DR, Carbone DP, Choy H, Dubinett SM, Gandara DR, Gaspar LE, Govindan R, Johnson DH, Minna JD, Scagliotti G, West HJ, Herbst RS. Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer. J Thorac Oncol. 2008 May; 3(5):545-55. PMID: 18449013.
      View in: PubMed
    79. Bunn PA. Diseases desperate grown. J Natl Cancer Inst. 2008 Apr 16; 100(8):520-1. PMID: 18398099.
      View in: PubMed
    80. Hirsch FR, Dziadziuszko R, Thatcher N, Mann H, Watkins C, Parums DV, Speake G, Holloway B, Bunn PA, Franklin WA. Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer. Cancer. 2008 Mar 01; 112(5):1114-21. PMID: 18219661.
      View in: PubMed
    81. Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, Varella-Garcia M, Bunn PA, Haney J, Helfrich BA, Kato H, Hirsch FR, Franklin WA. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol. 2008 Jun; 19(6):1053-9. PMID: 18304967.
      View in: PubMed
    82. Bunn PA, Thatcher N. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion. Oncologist. 2008; 13 Suppl 1:37-46. PMID: 18263773.
      View in: PubMed
    83. Byers T, Wolf HJ, Franklin WA, Braudrick S, Merrick DT, Shroyer KR, Hirsch FR, Zeng C, Barón AE, Bunn PA, Miller YE, Kennedy TC. Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity. Cancer Epidemiol Biomarkers Prev. 2008 Jan; 17(1):158-62. PMID: 18199720.
      View in: PubMed
    84. Bunn PA, Thatcher N. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction. Oncologist. 2008; 13 Suppl 1:1-4. PMID: 18263768.
      View in: PubMed
    85. Miller YE, Blatchford P, Hyun DS, Keith RL, Kennedy TC, Wolf H, Byers T, Bunn PA, Lewis MT, Franklin WA, Hirsch FR, Kittelson J. Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2425-31. PMID: 18006932.
      View in: PubMed
    86. Weiss GJ, Vokes EE, Bunn PA, Magree L, Rusk J, Albert D, Kelly K. Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial. J Thorac Oncol. 2007 Oct; 2(10):933-8. PMID: 17909356.
      View in: PubMed
    87. Dadds MR, Hunter K, Hawes DJ, Frost AD, Vassallo S, Bunn P, Merz S, Masry YE. A measure of cognitive and affective empathy in children using parent ratings. Child Psychiatry Hum Dev. 2008 Jun; 39(2):111-22. PMID: 17710538.
      View in: PubMed
    88. Bunn PA. Can acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors be overcome by different small-molecule tyrosine kinase inhibitors? J Clin Oncol. 2007 Jun 20; 25(18):2504-5. PMID: 17577025.
      View in: PubMed
    89. Taguchi F, Solomon B, Gregorc V, Roder H, Gray R, Kasahara K, Nishio M, Brahmer J, Spreafico A, Ludovini V, Massion PP, Dziadziuszko R, Schiller J, Grigorieva J, Tsypin M, Hunsucker SW, Caprioli R, Duncan MW, Hirsch FR, Bunn PA, Carbone DP. Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study. J Natl Cancer Inst. 2007 Jun 06; 99(11):838-46. PMID: 17551144.
      View in: PubMed
    90. Solomon B, Bunn PA. Adjuvant chemotherapy for non-small cell lung cancer. Cancer Invest. 2007 Jun; 25(4):217-25. PMID: 17612931.
      View in: PubMed
    91. Frederick BA, Helfrich BA, Coldren CD, Zheng D, Chan D, Bunn PA, Raben D. Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma. Mol Cancer Ther. 2007 Jun; 6(6):1683-91. PMID: 17541031.
      View in: PubMed
    92. Weiss GJ, Zeng C, Kelly K, Tran ZV, Bunn PA. Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer. Clin Lung Cancer. 2007 Mar; 8(5):335-8. PMID: 17562234.
      View in: PubMed
    93. Weiss GJ, Rosell R, Fossella F, Perry M, Stahel R, Barata F, Nguyen B, Paul S, McAndrews P, Hanna N, Kelly K, Bunn PA. The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer. Ann Oncol. 2007 Mar; 18(3):453-60. PMID: 17322539.
      View in: PubMed
    94. Hirsch FR, Varella-Garcia M, Cappuzzo F, McCoy J, Bemis L, Xavier AC, Dziadziuszko R, Gumerlock P, Chansky K, West H, Gazdar AF, Crino L, Gandara DR, Franklin WA, Bunn PA. Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. Ann Oncol. 2007 Apr; 18(4):752-60. PMID: 17317677.
      View in: PubMed
    95. Dziadziuszko R, Siemiatkowska A, Limon J, Rzyman W, Jassem J, Bunn PA, Varella-Garcia M, Hirsch FR. Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report. J Thorac Oncol. 2007 Jan; 2(1):91-2. PMID: 17410018.
      View in: PubMed
    96. Helfrich BA, Raben D, Varella-Garcia M, Gustafson D, Chan DC, Bemis L, Coldren C, Barón A, Zeng C, Franklin WA, Hirsch FR, Gazdar A, Minna J, Bunn PA. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels. Clin Cancer Res. 2006 Dec 01; 12(23):7117-25. PMID: 17145836.
      View in: PubMed
    97. Dziadziuszko R, Holm B, Skov BG, Osterlind K, Sellers MV, Franklin WA, Bunn PA, Varella-Garcia M, Hirsch FR. Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy. Ann Oncol. 2007 Mar; 18(3):447-52. PMID: 17082511.
      View in: PubMed
    98. Weiss GJ, Bunn PA, Camidge DR. From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer. Oncology (Williston Park). 2006 Nov; 20(12):1515-24; discussion 1524-5, 1530, 1535. PMID: 17153906.
      View in: PubMed
    99. Hirsch FR, Varella-Garcia M, Bunn PA, Franklin WA, Dziadziuszko R, Thatcher N, Chang A, Parikh P, Pereira JR, Ciuleanu T, von Pawel J, Watkins C, Flannery A, Ellison G, Donald E, Knight L, Parums D, Botwood N, Holloway B. Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer. J Clin Oncol. 2006 Nov 01; 24(31):5034-42. PMID: 17075123.
      View in: PubMed
    100. Bunn PA. Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer? Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):5919-20. PMID: 17062660.
      View in: PubMed
    101. Weiss GJ, Langer C, Rosell R, Hanna N, Shepherd F, Einhorn LH, Nguyen B, Paul S, McAndrews P, Bunn PA, Kelly K. Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer. J Clin Oncol. 2006 Sep 20; 24(27):4405-11. PMID: 16983108.
      View in: PubMed
    102. Coldren CD, Helfrich BA, Witta SE, Sugita M, Lapadat R, Zeng C, Barón A, Franklin WA, Hirsch FR, Geraci MW, Bunn PA. Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines. Mol Cancer Res. 2006 Aug; 4(8):521-8. PMID: 16877703.
      View in: PubMed
    103. Lynch TJ, Adjei AA, Bunn PA, Eisen TG, Engelman J, Goss GD, Haber DA, Heymach JV, Jänne PA, Johnson BE, Johnson DH, Lilenbaum RC, Meyerson M, Sandler AB, Sequist LV, Settleman J, Wong KK, Hart CS. Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 2):4365s-4371s. PMID: 16857812.
      View in: PubMed
    104. Dziadziuszko R, Hirsch FR, Varella-Garcia M, Bunn PA. Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how? Clin Cancer Res. 2006 Jul 15; 12(14 Pt 2):4409s-4415s. PMID: 16857819.
      View in: PubMed
    105. Bunn PA, Dziadziuszko R, Varella-Garcia M, Franklin WA, Witta SE, Kelly K, Hirsch FR. Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy. Clin Cancer Res. 2006 Jun 15; 12(12):3652-6. PMID: 16778092.
      View in: PubMed
    106. Dziadziuszko R, Witta SE, Cappuzzo F, Park S, Tanaka K, Danenberg PV, Barón AE, Crino L, Franklin WA, Bunn PA, Varella-Garcia M, Danenberg KD, Hirsch FR. Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer. Clin Cancer Res. 2006 May 15; 12(10):3078-84. PMID: 16707605.
      View in: PubMed
    107. Miller YE, Vu KO, Kennedy TC, Hirsch FR, Petty TL, Bunn PA, Keith RL, Franklin WA, Wolf HJ, Prindiville S, Byers T. Lack of association between sputum atypia and chronic obstructive pulmonary disease mortality. J Thorac Oncol. 2006 May; 1(4):302-7. PMID: 17409874.
      View in: PubMed
    108. Sunpaweravong P, Magree L, Rabinovitch R, Bunn P, Kelly K. A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer. Invest New Drugs. 2006 May; 24(3):213-21. PMID: 16193241.
      View in: PubMed
    109. Hanna N, Bunn PA, Langer C, Einhorn L, Guthrie T, Beck T, Ansari R, Ellis P, Byrne M, Morrison M, Hariharan S, Wang B, Sandler A. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol. 2006 May 01; 24(13):2038-43. PMID: 16648503.
      View in: PubMed
    110. Cappuzzo F, Toschi L, Tallini G, Ceresoli GL, Domenichini I, Bartolini S, Finocchiaro G, Magrini E, Metro G, Cancellieri A, Trisolini R, Crino L, Bunn PA, Santoro A, Franklin WA, Varella-Garcia M, Hirsch FR. Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib. Ann Oncol. 2006 Jul; 17(7):1120-7. PMID: 16600976.
      View in: PubMed
    111. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res. 2006 Mar 15; 66(6):3338-44. PMID: 16540689.
      View in: PubMed
    112. Witta SE, Gemmill RM, Hirsch FR, Coldren CD, Hedman K, Ravdel L, Helfrich B, Dziadziuszko R, Chan DC, Sugita M, Chan Z, Baron A, Franklin W, Drabkin HA, Girard L, Gazdar AF, Minna JD, Bunn PA. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 2006 Jan 15; 66(2):944-50. PMID: 16424029.
      View in: PubMed
    113. Cappuzzo F, Toschi L, Domenichini I, Bartolini S, Ceresoli GL, Rossi E, Ludovini V, Cancellieri A, Magrini E, Bemis L, Franklin WA, Crino L, Bunn PA, Hirsch FR, Varella-Garcia M. HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients. Br J Cancer. 2005 Dec 12; 93(12):1334-40. PMID: 16288303.
      View in: PubMed
    114. Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, Bunn PA, Johnson GL, Hirsch FR, Merrick DT, Franklin WA, Baron AE, Keith RL, Nemenoff RA, Malkinson AM, Geraci MW. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol. 2005 Dec; 167(6):1763-75. PMID: 16314486.
      View in: PubMed
    115. Solomon B, Bunn PA. Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent. Future Oncol. 2005 Dec; 1(6):733-46. PMID: 16556051.
      View in: PubMed
    116. Hirsch FR, Bunn PA. Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations? J Clin Oncol. 2005 Dec 20; 23(36):9044-7. PMID: 16301593.
      View in: PubMed
    117. Solomon B, Mitchell JD, Bunn PA. Adjuvant chemotherapy for resected non-small-cell lung cancer. Oncology (Williston Park). 2005 Nov; 19(13):1685-97; discussion 1698-700, 1705. PMID: 16425522.
      View in: PubMed
    118. Thienelt CD, Bunn PA, Hanna N, Rosenberg A, Needle MN, Long ME, Gustafson DL, Kelly K. Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer. J Clin Oncol. 2005 Dec 01; 23(34):8786-93. PMID: 16246975.
      View in: PubMed
    119. Solomon B, Bunn PA. Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: similar survival to cisplatin plus vinorelbine and less toxicity. Cancer Treat Rev. 2005 Nov; 31(7):571-6. PMID: 16242243.
      View in: PubMed
    120. Stewart JM, Gera L, Chan DC, York EJ, Simkeviciene V, Bunn PA, Taraseviciene-Stewart L. Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists. Peptides. 2005 Aug; 26(8):1288-91. PMID: 15878795.
      View in: PubMed
    121. Cappuzzo F, Varella-Garcia M, Shigematsu H, Domenichini I, Bartolini S, Ceresoli GL, Rossi E, Ludovini V, Gregorc V, Toschi L, Franklin WA, Crino L, Gazdar AF, Bunn PA, Hirsch FR. Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J Clin Oncol. 2005 Aug 01; 23(22):5007-18. PMID: 16051952.
      View in: PubMed
    122. Hirsch FR, Varella-Garcia M, McCoy J, West H, Xavier AC, Gumerlock P, Bunn PA, Franklin WA, Crowley J, Gandara DR. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study. J Clin Oncol. 2005 Oct 01; 23(28):6838-45. PMID: 15998906.
      View in: PubMed
    123. Hirsch FR, Gandara DR, McCoy J, Crowley J, West HJ, Gummerlock PH, Bunn PA, Franklin WA, Varella-Garcia M. Increased EGFR gene copy number detected by fish is associated with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma (BAC) (S0126). J Clin Oncol. 2005 Jun; 23(16_suppl):7030. PMID: 27944483.
      View in: PubMed
    124. Witta SE, Helfrich B, Chan D, Hirsch F, Franklin W, Drabkin HA, Gemmill RM, Bunn PA. Overcoming resistance to EGFR inhibitors in NSCLC cell lines by sequential treatment with histone deacetylase inhibitors. J Clin Oncol. 2005 Jun; 23(16_suppl):7083. PMID: 27944545.
      View in: PubMed
    125. Hanna NH, Einhorn L, Sandler A, Langer C, Hariharan S, Ansari R, Ellis P, Byrne M, Wang B, Bunn P. Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC). J Clin Oncol. 2005 Jun; 23(16_suppl):LBA7004. PMID: 27943967.
      View in: PubMed
    126. Cappuzzo F, Toschi L, Shigematsu H, Rossi E, Ceresoli G, Crino L, Bunn PA, Gazdar AF, Hirsch FR, Varella-Garcia M. HER2 and HER3 genomic gain increases sensitivity to gefitinib in epidermal growth factor receptor positive advanced non-small cell lung cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):3021. PMID: 27945773.
      View in: PubMed
    127. Pisters K, Vallieres E, Bunn P, Crowley J, Ginsberg R, Ellis P, Meyers B, Marks R, Treat J, Gandara D. S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. J Clin Oncol. 2005 Jun; 23(16_suppl):LBA7012. PMID: 27943931.
      View in: PubMed
    128. Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S, Danenberg K, Domenichini I, Ludovini V, Magrini E, Gregorc V, Doglioni C, Sidoni A, Tonato M, Franklin WA, Crino L, Bunn PA, Varella-Garcia M. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst. 2005 May 04; 97(9):643-55. PMID: 15870435.
      View in: PubMed
    129. Kennedy TC, Franklin WA, Prindiville SA, Cook R, Dempsey EC, Keith RL, Hirsch FR, Merrick TA, Shroyer KR, Petty TL, Byers T, Bunn PA, Miller YE. High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia. Lung Cancer. 2005 Aug; 49(2):187-91. PMID: 16022912.
      View in: PubMed
    130. Bunn PA. Platinums in lung cancer: sufficient or necessary? J Clin Oncol. 2005 May 01; 23(13):2882-3. PMID: 15728220.
      View in: PubMed
    131. Raben D, Helfrich B, Chan DC, Ciardiello F, Zhao L, Franklin W, Barón AE, Zeng C, Johnson TK, Bunn PA. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):795-805. PMID: 15701870.
      View in: PubMed
    132. Witta SE, Gustafson DL, Pierson AS, Menter A, Holden SN, Basche M, Persky M, O'Bryant CL, Zeng C, Baron A, Long ME, Gibbs A, Kelly K, Bunn PA, Chan DC, Pallansch P, Eckhardt SG. A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors. Clin Cancer Res. 2004 Nov 01; 10(21):7229-37. PMID: 15534096.
      View in: PubMed
    133. Bunn PA. Early-stage NSCLC: the role of radiotherapy and systemic therapy. J Natl Compr Canc Netw. 2004 Sep; 2 Suppl 2:S31-40. PMID: 19780244.
      View in: PubMed
    134. Bunn PA. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy. Clin Lung Cancer. 2004 Sep; 6(2):85-98. PMID: 15476594.
      View in: PubMed
    135. Monnerat C, Le Chevalier T, Kelly K, Obasaju CK, Brahmer J, Novello S, Nakamura T, Liepa AM, Bozec L, Bunn PA, Ettinger DS. Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer. Clin Cancer Res. 2004 Aug 15; 10(16):5439-46. PMID: 15328182.
      View in: PubMed
    136. Raben D, Bianco C, Damiano V, Bianco R, Melisi D, Mignogna C, D'Armiento FP, Cionini L, Bianco AR, Tortora G, Ciardiello F, Bunn P. Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. Mol Cancer Ther. 2004 Aug; 3(8):977-83. PMID: 15299080.
      View in: PubMed
    137. Bunn P. New investigative regimens and cytotoxic agents in thoracic cancers: gemcitabine and pemetrexed. Oncology (Williston Park). 2004 Jul; 18(8 Suppl 5):5-11. PMID: 15339053.
      View in: PubMed
    138. Lynch TJ, Adjei AA, Bunn PA, DuBois RN, Gandara DR, Giaccone G, Govindan R, Herbst RS, Johnson BE, Khuri FR, Perez-Soler R, Rosell R, Rowinsky EK, Sandler AB, Scagliotti GV, Schiller JH, Shapiro GI, Socinski MA, Hart CS. Novel agents in the treatment of lung cancer: conference summary statement. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 2):4199s-4204s. PMID: 15217958.
      View in: PubMed
    139. Bunn PA. The potential role of proteasome inhibitors in the treatment of lung cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 2):4263s-4265s. PMID: 15217971.
      View in: PubMed
    140. Dadds MR, Whiting C, Bunn P, Fraser JA, Charlson JH, Pirola-Merlo A. Measurement of cruelty in children: the Cruelty to Animals Inventory. J Abnorm Child Psychol. 2004 Jun; 32(3):321-34. PMID: 15228180.
      View in: PubMed
    141. Kennedy TC, Franklin WA, Prindiville SA, Cook R, Dempsey EC, Keith RL, Hirsch FR, Merrick TA, Shroyer KR, Petty TL, Byers T, Bunn PA, Miller YE. High prevalence of endobronchial malignancy in high-risk patients with moderate dysplasia in sputum. Chest. 2004 May; 125(5 Suppl):109S. PMID: 15136448.
      View in: PubMed
    142. Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, Lim HL, Desch C, Szondy K, Gervais R. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol. 2004 May 01; 22(9):1589-97. PMID: 15117980.
      View in: PubMed
    143. Winterhalder RC, Hirsch FR, Kotantoulas GK, Franklin WA, Bunn PA. Chemoprevention of lung cancer--from biology to clinical reality. Ann Oncol. 2004 Feb; 15(2):185-96. PMID: 14760107.
      View in: PubMed
    144. Raben D, Helfrich B, Bunn PA. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective. Int J Radiat Oncol Biol Phys. 2004; 59(2 Suppl):27-38. PMID: 15142632.
      View in: PubMed
    145. Bunn PA. Implementing ASCO's strategic plan 2003: diverse membership needs, prevention, and patient partnerships. J Clin Oncol. 2003 Dec 01; 21(23 Suppl):231s-236s. PMID: 14645396.
      View in: PubMed
    146. Herbst RS, Bunn PA. Targeting the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):5813-24. PMID: 14676101.
      View in: PubMed
    147. Prindiville SA, Byers T, Hirsch FR, Franklin WA, Miller YE, Vu KO, Wolf HJ, Barón AE, Shroyer KR, Zeng C, Kennedy TC, Bunn PA. Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):987-93. PMID: 14578133.
      View in: PubMed
    148. Hirsch FR, Varella-Garcia M, Bunn PA, Di Maria MV, Veve R, Bremmes RM, Barón AE, Zeng C, Franklin WA. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol. 2003 Oct 15; 21(20):3798-807. PMID: 12953099.
      View in: PubMed
    149. Raben D, Helfrich B, Ciardiello F, Bunn PA. Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know. Lung Cancer. 2003 Aug; 41 Suppl 1:S15-22. PMID: 12867058.
      View in: PubMed
    150. Bunn PA, Shepherd FA, Sandler A, Le Chevalier T, Belani CP, Kosmidis PA, Scagliotti GV, Giaccone G. Ongoing and future trials of biologic therapies in lung cancer. Lung Cancer. 2003 Aug; 41 Suppl 1:S175-86. PMID: 12867076.
      View in: PubMed
    151. Hirsch FR, Bunn PA, Johnson DH, Giaccone G, Rosell R. Lung cancer. Introduction. Lung Cancer. 2003 Aug; 41 Suppl 1:S1. PMID: 12867055.
      View in: PubMed
    152. Whitehead CM, Earle KA, Fetter J, Xu S, Hartman T, Chan DC, Zhao TL, Piazza G, Klein-Szanto AJ, Pamukcu R, Alila H, Bunn PA, Thompson WJ. Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival. Mol Cancer Ther. 2003 May; 2(5):479-88. PMID: 12748310.
      View in: PubMed
    153. Bunn PA, Lilenbaum R. Chemotherapy for elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst. 2003 Mar 05; 95(5):341-3. PMID: 12618492.
      View in: PubMed
    154. Simon GR, Bunn PA. Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments. Cancer Invest. 2003; 21(1):87-104. PMID: 12643013.
      View in: PubMed
    155. Niyikiza C, Hanauske AR, Rusthoven JJ, Calvert AH, Allen R, Paoletti P, Bunn PA. Pemetrexed safety and dosing strategy. Semin Oncol. 2002 Dec; 29(6 Suppl 18):24-9. PMID: 12571807.
      View in: PubMed
    156. Stewart JM, Chan DC, Simkeviciene V, Bunn PA, Helfrich B, York EJ, Taraseviciene-Stewart L, Bironaite D, Gera L. Bradykinin antagonists as new drugs for prostate cancer. Int Immunopharmacol. 2002 Dec; 2(13-14):1781-6. PMID: 12489792.
      View in: PubMed
    157. Bunn PA. Current therapeutic approaches in lung cancer. Clin Lung Cancer. 2002 Nov; 4 Suppl 1:S4. PMID: 14659033.
      View in: PubMed
    158. Bunn PA. The role of irinotecan combined with Cisplatin or Carboplatin in the treatment of advanced non-small-cell lung cancer. Clin Lung Cancer. 2002 Nov; 4 Suppl 1:S5-9. PMID: 14659034.
      View in: PubMed
    159. Bunn PA, Franklin W. Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer. Semin Oncol. 2002 Oct; 29(5 Suppl 14):38-44. PMID: 12422312.
      View in: PubMed
    160. Bunn PA. Molecular biology and early diagnosis in lung cancer. Lung Cancer. 2002 Oct; 38(1):S5-8. PMID: 12367806.
      View in: PubMed
    161. Bunn PA. Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why? J Clin Oncol. 2002 Sep 15; 20(18 Suppl):23S-33S. PMID: 12235221.
      View in: PubMed
    162. Hirsch FR, Bunn PA, Dmitrovsky E, Field JK, Franklin WA, Greenberg RE, Hansen HH, Henschke CI, Rigas JR, Smith RA, Toennesen P, Mulshine JL. IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001. Lung Cancer. 2002 Sep; 37(3):325-44. PMID: 12234703.
      View in: PubMed
    163. Bunn PA. Treatment of advanced non-small-cell lung cancer with two-drug combinations. J Clin Oncol. 2002 Sep 01; 20(17):3565-7. PMID: 12202651.
      View in: PubMed
    164. Griffiths HJ, Wagner J, Anglen J, Bunn P, Metzler M. The use of forced flexion/extension views in the obtunded trauma patient. Skeletal Radiol. 2002 Oct; 31(10):587-91. PMID: 12324828.
      View in: PubMed
    165. Bunn PA. New targeted therapies for lung cancer: expectations and reality. MedGenMed. 2002 Aug 05; 4(3):12. PMID: 12466755.
      View in: PubMed
    166. Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res. 2002 Jul 15; 62(14):3971-9. PMID: 12124329.
      View in: PubMed
    167. Hirsch FR, Franklin WA, Bunn PA. What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer? Lung Cancer. 2002 Jun; 36(3):263-4. PMID: 12009235.
      View in: PubMed
    168. Hirsch FR, Franklin WA, Bunn PA. Expression of target molecules in lung cancer: challenge for a new treatment paradigm. Semin Oncol. 2002 Jun; 29(3 Suppl 9):2-8. PMID: 12094332.
      View in: PubMed
    169. Bunn PA. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors). Semin Oncol. 2002 Jun; 29(3 Suppl 9):17-22. PMID: 12094334.
      View in: PubMed
    170. Hirsch FR, Varella-Garcia M, Franklin WA, Veve R, Chen L, Helfrich B, Zeng C, Baron A, Bunn PA. Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas. Br J Cancer. 2002 May 06; 86(9):1449-56. PMID: 11986780.
      View in: PubMed
    171. Bunn PA, Keith RL. The future of cyclooxygenase-2 inhibitors and other inhibitors of the eicosanoid signal pathway in the prevention and therapy of lung cancer. Clin Lung Cancer. 2002 May; 3(4):271-7; discussion 278. PMID: 14662036.
      View in: PubMed
    172. Hirsch FR, Helfrich B, Franklin WA, Varella-Garcia M, Chan DC, Bunn PA. Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines. Clin Breast Cancer. 2002 May; 3 Suppl 1:12-6. PMID: 12057039.
      View in: PubMed
    173. Chan DC, Gera L, Stewart JM, Helfrich B, Zhao TL, Feng WY, Chan KK, Covey JM, Bunn PA. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Clin Cancer Res. 2002 May; 8(5):1280-7. PMID: 12006549.
      View in: PubMed
    174. Chan D, Gera L, Stewart J, Helfrich B, Verella-Garcia M, Johnson G, Baron A, Yang J, Puck T, Bunn P. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a "biased agonist" mechanism. Proc Natl Acad Sci U S A. 2002 Apr 02; 99(7):4608-13. PMID: 11930011.
      View in: PubMed
    175. Postmus PE, Bunn PA. Pemetrexed as a single agent in the therapy of advanced lung cancer. Semin Oncol. 2002 Apr; 29(2 Suppl 5):17-22. PMID: 12023788.
      View in: PubMed
    176. Stewart JM, Gera L, Chan DC, Bunn PA, York EJ, Simkeviciene V, Helfrich B. Bradykinin-related compounds as new drugs for cancer and inflammation. Can J Physiol Pharmacol. 2002 Apr; 80(4):275-80. PMID: 12025961.
      View in: PubMed
    177. Calvert H, Bunn PA. Future directions in the development of pemetrexed. Semin Oncol. 2002 Apr; 29(2 Suppl 5):54-61. PMID: 12023794.
      View in: PubMed
    178. Chan DC, Earle KA, Zhao TL, Helfrich B, Zeng C, Baron A, Whitehead CM, Piazza G, Pamukcu R, Thompson WJ, Alila H, Nelson P, Bunn PA. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors. Clin Cancer Res. 2002 Mar; 8(3):904-12. PMID: 11895925.
      View in: PubMed
    179. Raben D, Helfrich BA, Chan D, Johnson G, Bunn PA. ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin Oncol. 2002 Feb; 29(1 Suppl 4):37-46. PMID: 11894012.
      View in: PubMed
    180. Bunn PA, Chan DC, Earle K, Zhao TL, Helfrich B, Kelly K, Piazza G, Whitehead CM, Pamukcu R, Thompson W, Alila H. Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer. Semin Oncol. 2002 Feb; 29(1 Suppl 4):87-94. PMID: 11894018.
      View in: PubMed
    181. Hirsch FR, Franklin WA, Veve R, Varella-Garcia M, Bunn PA. HER2/neu expression in malignant lung tumors. Semin Oncol. 2002 Feb; 29(1 Suppl 4):51-8. PMID: 11894014.
      View in: PubMed
    182. Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol. 2002 Feb; 29(1 Suppl 4):3-14. PMID: 11894009.
      View in: PubMed
    183. Bunn PA, Johnson DH. Seminars in oncology. Introduction. Semin Oncol. 2002 Feb; 29(1 Suppl 4):1-2. PMID: 11894008.
      View in: PubMed
    184. Anglen J, Metzler M, Bunn P, Griffiths H. Flexion and extension views are not cost-effective in a cervical spine clearance protocol for obtunded trauma patients. J Trauma. 2002 Jan; 52(1):54-9. PMID: 11791052.
      View in: PubMed
    185. Bunn PA. Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'. Ann Oncol. 2001 Oct; 12(10):1339-40. PMID: 11762802.
      View in: PubMed
    186. Bunn PA, Helfrich B, Soriano AF, Franklin WA, Varella-Garcia M, Hirsch FR, Baron A, Zeng C, Chan DC. Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. Clin Cancer Res. 2001 Oct; 7(10):3239-50. PMID: 11595720.
      View in: PubMed
    187. Hirsch FR, Prindiville SA, Miller YE, Franklin WA, Dempsey EC, Murphy JR, Bunn PA, Kennedy TC. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst. 2001 Sep 19; 93(18):1385-91. PMID: 11562389.
      View in: PubMed
    188. Kelly K, Lovato L, Bunn PA, Livingston RB, Zangmeister J, Taylor SA, Roychowdhury D, Crowley JJ, Gandara DR. Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group. Clin Cancer Res. 2001 Aug; 7(8):2325-9. PMID: 11489808.
      View in: PubMed
    189. Bunn PA. [State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer]. Anticancer Drugs. 2001 Jul; 12 Suppl 3:S3-8. PMID: 11556251.
      View in: PubMed
    190. Kelly K, Crowley J, Bunn PA, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, Israel VK, Livingston RB, Gandara DR. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol. 2001 Jul 01; 19(13):3210-8. PMID: 11432888.
      View in: PubMed
    191. Bunn PA. Irinotecan and platinums in the treatment of non small-cell lung cancer. Clin Lung Cancer. 2001 May; 2 Suppl 2:S14-9. PMID: 14725725.
      View in: PubMed
    192. Bunn PA. Triplet combination chemotherapy and targeted therapy regimens. Oncology (Williston Park). 2001 Mar; 15(3 Suppl 6):26-32. PMID: 11301845.
      View in: PubMed
    193. Khorana A, Bunn P, McLaughlin P, Vose J, Stewart C, Czuczman MS. A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma. Leuk Lymphoma. 2001 Mar; 41(1-2):77-87. PMID: 11342359.
      View in: PubMed
    194. Hirsch FR, Franklin WA, Gazdar AF, Bunn PA. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res. 2001 Jan; 7(1):5-22. PMID: 11205917.
      View in: PubMed
    195. Stewart JM, Gera L, York EJ, Chan DC, Whalley EJ, Bunn PA, Vavrek RJ. Metabolism-resistant bradykinin antagonists: development and applications. Biol Chem. 2001 Jan; 382(1):37-41. PMID: 11258669.
      View in: PubMed
    196. Bunn PA, Kelly K. Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer. Clin Lung Cancer. 2000 Dec; 2 Suppl 1:S23-8. PMID: 14725732.
      View in: PubMed
    197. Agus DB, Bunn PA, Franklin W, Garcia M, Ozols RF. HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer. Semin Oncol. 2000 Dec; 27(6 Suppl 11):53-63; discussion 92-100. PMID: 11236029.
      View in: PubMed
    198. Calvo R, West J, Franklin W, Erickson P, Bemis L, Li E, Helfrich B, Bunn P, Roche J, Brambilla E, Rosell R, Gemmill RM, Drabkin HA. Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A. 2000 Nov 07; 97(23):12776-81. PMID: 11070089.
      View in: PubMed
    199. Wood ME, Kelly K, Mullineaux LG, Bunn PA. The inherited nature of lung cancer: a pilot study. Lung Cancer. 2000 Nov; 30(2):135-44. PMID: 11086207.
      View in: PubMed
    200. Kelly K, Mikhaeel-Kamel N, Pan Z, Murphy J, Prindiville S, Bunn PA. A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer. Clin Cancer Res. 2000 Sep; 6(9):3474-9. PMID: 10999731.
      View in: PubMed
    201. Bunn PA, Mault J, Kelly K. Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment? Chest. 2000 Apr; 117(4 Suppl 1):119S-122S. PMID: 10777465.
      View in: PubMed
    202. Bunn PA, Kelly K. New combinations in the treatment of lung cancer: a time for optimism. Chest. 2000 Apr; 117(4 Suppl 1):138S-143S. PMID: 10777469.
      View in: PubMed
    203. Bunn PA, Soriano A, Johnson G, Heasley L. New therapeutic strategies for lung cancer: biology and molecular biology come of age. Chest. 2000 Apr; 117(4 Suppl 1):163S-168S. PMID: 10777473.
      View in: PubMed
    204. Pisters KM, Ginsberg RJ, Giroux DJ, Putnam JB, Kris MG, Johnson DH, Roberts JR, Mault J, Crowley JJ, Bunn PA. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team. J Thorac Cardiovasc Surg. 2000 Mar; 119(3):429-39. PMID: 10694600.
      View in: PubMed
    205. Soriano AF, Helfrich B, Chan DC, Heasley LE, Bunn PA, Chou TC. Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res. 1999 Dec 15; 59(24):6178-84. PMID: 10626810.
      View in: PubMed
    206. Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer. Clin Cancer Res. 1999 Nov; 5(11):3419-24. PMID: 10589753.
      View in: PubMed
    207. Stewart JM, Gera L, York EJ, Chan DC, Bunn P. Bradykinin antagonists: present progress and future prospects. Immunopharmacology. 1999 Sep; 43(2-3):155-61. PMID: 10596848.
      View in: PubMed
    208. Bunn PA. Immune therapy for lung cancer: are we getting closer? Am J Respir Cell Mol Biol. 1999 Jul; 21(1):10-2. PMID: 10385587.
      View in: PubMed
    209. Bunn PA. Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer. Semin Oncol. 1999 Feb; 26(1 Suppl 4):25-30. PMID: 10201518.
      View in: PubMed
    210. Bunn PA, Helfrich BA, Brenner DG, Chan DC, Dykes DJ, Cohen AJ, Miller YE. Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo. Clin Cancer Res. 1998 Nov; 4(11):2849-58. PMID: 9829752.
      View in: PubMed
    211. Bunn PA. Triplet chemotherapy combinations with new agents: is there a rationale? Semin Oncol. 1998 Aug; 25(4 Suppl 9):55-61. PMID: 9728586.
      View in: PubMed
    212. Bunn PA, Vokes EE, Langer CJ, Schiller JH. An update on North American randomized studies in non-small cell lung cancer. Semin Oncol. 1998 Aug; 25(4 Suppl 9):2-10. PMID: 9728578.
      View in: PubMed
    213. Bunn PA, Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions. Clin Cancer Res. 1998 May; 4(5):1087-100. PMID: 9607565.
      View in: PubMed
    214. Kelly K, Bunn PA. Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer? Lung Cancer. 1998 May; 20(2):85-91. PMID: 9711526.
      View in: PubMed
    215. Bunn PA. Cancer and acquired immunodeficiency syndrome wasting syndromes: current and future therapies. Semin Oncol. 1998 Apr; 25(2 Suppl 6):1-3. PMID: 9625376.
      View in: PubMed
    216. Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA, Stemmerman G, Wells JD, Macdonald JS, Meyskens FL. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res. 1998 Mar 15; 58(6):1149-58. PMID: 9515799.
      View in: PubMed
    217. Beekman A, Helfrich B, Bunn PA, Heasley LE. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth. Cancer Res. 1998 Mar 01; 58(5):910-3. PMID: 9500449.
      View in: PubMed
    218. Kelly K, Hazuka M, Pan Z, Murphy J, Caskey J, Leonard C, Bunn PA. A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1998 Feb 01; 40(3):559-67. PMID: 9486605.
      View in: PubMed
    219. Chan DC, Geraci M, Bunn PA. Anti-growth factor therapy for lung cancer. Drug Resist Updat. 1998; 1(6):377-88. PMID: 17092819.
      View in: PubMed
    220. Pisters KM, Kris MG, Bunn PA, Johnson DH, Ruckdeschel JC, Crowley JJ, Ginsberg RJ. Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-41-S12-44. PMID: 9331120.
      View in: PubMed
    221. Bunn PA, Kelly K. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PMID: 9331140.
      View in: PubMed
    222. Bunn PA. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PMID: 9331142.
      View in: PubMed
    223. Kelly K, Pan Z, Murphy J, Huffman DH, Bunn PA. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer. Clin Cancer Res. 1997 Jul; 3(7):1117-23. PMID: 9815791.
      View in: PubMed
    224. Bunn PA, Kelly K. Systemic investigational therapies as adjuvants to surgery in patients with operable lung cancer. Semin Oncol. 1997 Jun; 24(3 Suppl 8):S8-46-S8-52. PMID: 9207318.
      View in: PubMed
    225. Bunn PA. The emerging role of gemcitabine in lung cancer. Semin Oncol. 1997 Jun; 24(3 Suppl 8):S8-1. PMID: 9207307.
      View in: PubMed
    226. Cohen AJ, Skidgel RA, Gilman LB, Black JK, Bunn PA, Helfrich B, Franklin WA, Miller YE. Carboxypeptidase M. Variable expression in normal human lung and inactivation in lung cancer. Chest. 1997 Jun; 111(6 Suppl):149S. PMID: 9184569.
      View in: PubMed
    227. Dinarello CA, Bunn PA. Fever. Semin Oncol. 1997 Jun; 24(3):288-98. PMID: 9208885.
      View in: PubMed
    228. Bunn PA, Carney DN. Overview of chemotherapy for small cell lung cancer. Semin Oncol. 1997 Apr; 24(2 Suppl 7):S7-69-S7-74. PMID: 9194484.
      View in: PubMed
    229. Bunn PA. The emerging role of gemcitabine in lung cancer: part I. Semin Oncol. 1997 Apr; 24(2 Suppl 7):S7-1. PMID: 9194472.
      View in: PubMed
    230. Bunn P, Carbone D, Grim J, Harris C, Havemann K, Mabry M, Roth J, Saijo N, Poulsen HS, Stahel R, Takahashi T, Twentyman P. 5th I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, Switzerland. Lung Cancer. 1997 Mar; 16(2-3):239-57. PMID: 9152955.
      View in: PubMed
    231. Bunn P, Carbone D, Grim J, Harris C, Havemann K, Mabry M, Roth J, Saijo N, Poulsen HS, Stahel R, Takahashi T, Twentyman P. Fifth I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, Switzerland. Ann Oncol. 1997 Jan; 8(1):27-36. PMID: 9093704.
      View in: PubMed
    232. Bunn PA. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer. Semin Oncol. 1996 Dec; 23(6 Suppl 16):18-25. PMID: 9007116.
      View in: PubMed
    233. Bunn PA, Kelly K. Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study. Semin Oncol. 1996 Dec; 23(6 Suppl 16):11-5. PMID: 9007114.
      View in: PubMed
    234. Bunn PA. Future directions in therapeutic approaches for small cell lung cancer. Semin Oncol. 1996 Dec; 23(6 Suppl 16):136-8. PMID: 9007141.
      View in: PubMed
    235. Bunn PA. Combination paclitaxel and platinum in the treatment of lung cancer: US experience. Semin Oncol. 1996 Dec; 23(6 Suppl 15):9-15. PMID: 8996590.
      View in: PubMed
    236. Bunn PA. Current therapy of small cell lung cancer. Semin Oncol. 1996 Dec; 23(6 Suppl 16):1-4. PMID: 9007111.
      View in: PubMed
    237. Leonard CE, Chan DC, Chou TC, Kumar R, Bunn PA. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res. 1996 Nov 15; 56(22):5198-204. PMID: 8912857.
      View in: PubMed
    238. Franklin WA, Folkvord JM, Varella-Garcia M, Kennedy T, Proudfoot S, Cook R, Dempsey EC, Helm K, Bunn PA, Miller YE. Expansion of bronchial epithelial cell populations by in vitro culture of explants from dysplastic and histologically normal sites. Am J Respir Cell Mol Biol. 1996 Sep; 15(3):297-304. PMID: 8810633.
      View in: PubMed
    239. Chan D, Gera L, Helfrich B, Helm K, Stewart J, Whalley E, Bunn P. Novel bradykinin antagonist dimers for the treatment of human lung cancers. Immunopharmacology. 1996 Jun; 33(1-3):201-4. PMID: 8856150.
      View in: PubMed
    240. Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cancer Res. 1996 Feb 15; 56(4):831-9. PMID: 8631021.
      View in: PubMed
    241. Heasley LE, Zamarripa J, Storey B, Helfrich B, Mitchell FM, Bunn PA, Johnson GL. Discordant signal transduction and growth inhibition of small cell lung carcinomas induced by expression of GTPase-deficient G alpha 16. J Biol Chem. 1996 Jan 05; 271(1):349-54. PMID: 8550585.
      View in: PubMed
    242. Bunn PA, Foss FM. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL). J Cell Biochem Suppl. 1996; 24:12-23. PMID: 8806090.
      View in: PubMed
    243. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn PA, Carney D, Minna JD, Mulshine JL. NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl. 1996; 24:32-91. PMID: 8806092.
      View in: PubMed
    244. Kelly K, Crowley JJ, Bunn PA, Hazuka MB, Beasley K, Upchurch C, Weiss GR, Hicks WJ, Gandara DR, Rivkin S, et al. Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study. J Clin Oncol. 1995 Dec; 13(12):2924-30. PMID: 8523056.
      View in: PubMed
    245. Bunn PA, Kelly KL. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study. Semin Oncol. 1995 Oct; 22(5 Suppl 12):54-8; discussion 59-60. PMID: 7481862.
      View in: PubMed
    246. Olsen EA, Bunn PA. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995 Oct; 9(5):1089-107. PMID: 8522486.
      View in: PubMed
    247. Bunn PA, Kelly K. A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: a University of Colorado Cancer Center study. Semin Oncol. 1995 Aug; 22(4 Suppl 9):2-6. PMID: 7644924.
      View in: PubMed
    248. Bunn PA, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livingston R, Weiss GR, Hicks WJ, Gandara DR, et al. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group. J Clin Oncol. 1995 Jul; 13(7):1632-41. PMID: 7602352.
      View in: PubMed
    249. Bunn PA, Kelly K. New treatment agents for advanced small cell and non-small cell lung cancer. Semin Oncol. 1995 Jun; 22(3 Suppl 6):53-63. PMID: 7597434.
      View in: PubMed
    250. Bunn PA. Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy? Arch Dermatol. 1995 May; 131(5):603-5. PMID: 7537952.
      View in: PubMed
    251. Bunn PA, Kelly K. Prophylactic cranial irradiation for patients with small-cell lung cancer. J Natl Cancer Inst. 1995 Feb 01; 87(3):161-2. PMID: 7707398.
      View in: PubMed
    252. Bunn PA. Future directions in clinical research for lung cancer. Chest. 1994 Dec; 106(6 Suppl):399S-407S. PMID: 7988273.
      View in: PubMed
    253. Bunn PA, Hoffman SJ, Norris D, Golitz LE, Aeling JL. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome). Ann Intern Med. 1994 Oct 15; 121(8):592-602. PMID: 8085692.
      View in: PubMed
    254. Hazuka MB, Crowley JJ, Bunn PA, O'Rourke M, Braun TJ, Livingston RB. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study. J Clin Oncol. 1994 Sep; 12(9):1814-20. PMID: 8083705.
      View in: PubMed
    255. Bunn PA, Chan D, Stewart J, Gera L, Tolley R, Jewett P, Tagawa M, Alford C, Mochzuki T, Yanaihara N. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines. Cancer Res. 1994 Jul 01; 54(13):3602-10. PMID: 7516822.
      View in: PubMed
    256. Bunn PA. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions. Semin Oncol. 1994 Jun; 21(3 Suppl 6):49-59. PMID: 8052874.
      View in: PubMed
    257. Bunn P, Arriagada R, Choi N, Feld R, Gregor A, Jett J, Johnson B, Komaki R, Kristjansen P, Murray N, et al. Combined modality therapy in small cell lung cancer. Lung Cancer. 1994 Mar; 10 Suppl 1:S25-8. PMID: 8087517.
      View in: PubMed
    258. Bunn PA. Cutaneous T cell lymphomas. BMJ. 1994 Feb 26; 308(6928):551-2. PMID: 8031362.
      View in: PubMed
    259. Franklin WA, Waintrub M, Edwards D, Christensen K, Prendegrast P, Woods J, Bunn PA, Kolhouse JF. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int J Cancer Suppl. 1994; 8:89-95. PMID: 8194901.
      View in: PubMed
    260. Haugen BR, Nawaz S, Cohn A, Shroyer K, Bunn PA, Liechty DR, Ridgway EC. Secondary malignancy of the thyroid gland: a case report and review of the literature. Thyroid. 1994; 4(3):297-300. PMID: 7833666.
      View in: PubMed
    261. Bunn PA, Van Zandwijk N, Pastorino U, Aisner J, Alberto P, Arriagada R, Carney D, Cornis R, Dittrich C, Gatzemeier U, et al. European School of Oncology. First Euro-American Forum on Lung Cancer Treatment. Eur J Cancer. 1994; 30A(5):710-3. PMID: 8080692.
      View in: PubMed
    262. Bunn PA, Kelly K. The role of routine chest radiotherapy in small-cell lung cancer. An issue of timing and stage. Chest. 1993 Sep; 104(3):661-2. PMID: 8395999.
      View in: PubMed
    263. Bunn PA, Whang-Peng J, Gazdar AF, Minna JD, Carney D. Karyotypic derivation of H9 cell line. J Natl Cancer Inst. 1993 Jul 21; 85(14):1168-9. PMID: 8320746.
      View in: PubMed
    264. Cook RM, Miller YE, Bunn PA. Small cell lung cancer: etiology, biology, clinical features, staging, and treatment. Curr Probl Cancer. 1993 Mar-Apr; 17(2):69-141. PMID: 8395998.
      View in: PubMed
    265. Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, Bunn PA, Mabry M, Dykes DJ, Harrison SD, et al. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl. Cancer Res. 1992 Sep 01; 52(17):4752-7. PMID: 1324793.
      View in: PubMed
    266. Taylor CW, Chase EM, Whitehead RP, Rinehart JJ, Neidhart JA, Gonzalez R, Bunn PA, Hersh EM. A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancer. J Immunother (1991). 1992 Apr; 11(3):176-83. PMID: 1515422.
      View in: PubMed
    267. Hazuka MB, Bunn PA. Controversies in the nonsurgical treatment of stage III non-small cell lung cancer. Am Rev Respir Dis. 1992 Apr; 145(4 Pt 1):967-77. PMID: 1313216.
      View in: PubMed
    268. Bunn PA. Clinical experiences with carboplatin (paraplatin) in lung cancer. Semin Oncol. 1992 Feb; 19(1 Suppl 2):1-11. PMID: 1329216.
      View in: PubMed
    269. Kemme DJ, Bunn PA. State of the art therapy of mycosis fungoides and Sézary syndrome. Oncology (Williston Park). 1992 Feb; 6(2):31-42; discussion 44, 47-8. PMID: 1532501.
      View in: PubMed
    270. Mulvin DW, Howard RB, Mitchell DH, Noker PE, Kruse CA, Chu HD, Bunn PA, Johnston MR. Secondary screening system for preclinical testing of human lung cancer therapies. J Natl Cancer Inst. 1992 Jan 01; 84(1):31-7. PMID: 1310746.
      View in: PubMed
    271. Bunn PA, Chan D, Dienhart DG, Tolley R, Tagawa M, Jewett PB. Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity. Cancer Res. 1992 Jan 01; 52(1):24-31. PMID: 1309227.
      View in: PubMed
    272. Bunn PA, Dienhart DG, Chan D, Tagawa M, Jewett P. Effects of neuropeptides on human lung and breast cancer cells. J Natl Cancer Inst Monogr. 1992; (13):145-51. PMID: 1389687.
      View in: PubMed
    273. Johnson TK, Gonzalez R, Kasliwal RK, Lear JL, Feyerabend AJ, Dienhart DG, Ceriani RL, Bunn PA. Distribution of a breast-directed I-131-radiolabeled monoclonal antibody in blood and bone marrow: implications for radiation immunotherapy. Radiology. 1992 Jan; 182(1):107-14. PMID: 1727271.
      View in: PubMed
    274. Gonzalez R, Salem P, Bunn PA, Zukiwski AA, Lamb R, Benjamin RS, Spitler L, Wedel N, Robinson WA. Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial. Mol Biother. 1991 Dec; 3(4):192-6. PMID: 1768370.
      View in: PubMed
    275. Hartmann C, Bloedow DC, Dienhart DG, Kasliwal R, Johnson TK, Gonzalez R, Bunn PA. A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorption. J Pharmacokinet Biopharm. 1991 Aug; 19(4):385-403. PMID: 1920086.
      View in: PubMed
    276. Hazuka MB, Bunn PA, Crowley J. Maximum tolerated dose for low-dose continuous infusion cisplatin. Int J Radiat Oncol Biol Phys. 1991 Aug; 21(3):869-70. PMID: 1651311.
      View in: PubMed
    277. Howard RB, Chu H, Zeligman BE, Marcell T, Bunn PA, McLemore TL, Mulvin DW, Cowen ME, Johnston MR. Irradiated nude rat model for orthotopic human lung cancers. Cancer Res. 1991 Jun 15; 51(12):3274-80. PMID: 2040002.
      View in: PubMed
    278. Lear JL, Kasliwal RK, Feyerabend AJ, Pratt JP, Bunn PA, Dienhart DG, Gonzalez R, Johnson TK, Bloedow DC, Maddock SW, et al. Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody column. Radiology. 1991 May; 179(2):509-12. PMID: 1849662.
      View in: PubMed
    279. Mulshine JL, Carrasquillo JA, Weinstein JN, Keenan AM, Reynolds JC, Herdt J, Bunn PA, Sausville E, Eddy J, Cotelingam JD, et al. Direct intralymphatic injection of radiolabeled 111In-T101 in patients with cutaneous T-cell lymphoma. Cancer Res. 1991 Jan 15; 51(2):688-95. PMID: 1985786.
      View in: PubMed
    280. Kelly K, Kane MA, Bunn PA. Growth factors in lung cancer: possible etiologic role and clinical target. Med Pediatr Oncol. 1991; 19(6):450-8. PMID: 1660094.
      View in: PubMed
    281. Lamb R, Gonzalez R, Myers A, Bunn P, Robinson W. Aggressive non-Hodgkin's lymphomas in AIDS: the University of Colorado experience. Am J Med Sci. 1990 Dec; 300(6):345-9. PMID: 2264571.
      View in: PubMed
    282. Roenigk HH, Kuzel TM, Skoutelis AP, Springer E, Yu G, Caro W, Gilyon K, Variakojis D, Kaul K, Bunn PA, et al. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol. 1990 Dec; 95(6 Suppl):198S-205S. PMID: 2258636.
      View in: PubMed
    283. Bunn PA, Norris DA. The therapeutic role of interferons and monoclonal antibodies in cutaneous T-cell lymphomas. J Invest Dermatol. 1990 Dec; 95(6 Suppl):209S-212S. PMID: 1701807.
      View in: PubMed
    284. Longley C, Furmanski P, Dienhart DG, Lear J, Bloedow D, Kasliwal R, Bunn PA. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts. Cancer Res. 1990 Sep 15; 50(18):5954-61. PMID: 2393864.
      View in: PubMed
    285. Bunn PA. Operation for stage IIIa small cell lung cancer? Ann Thorac Surg. 1990 May; 49(5):691. PMID: 2160225.
      View in: PubMed
    286. Bunn PA, Dienhart DG, Chan D, Puck TT, Tagawa M, Jewett PB, Braunschweiger E. Neuropeptide stimulation of calcium flux in human lung cancer cells: delineation of alternative pathways. Proc Natl Acad Sci U S A. 1990 Mar; 87(6):2162-6. PMID: 2156263.
      View in: PubMed
    287. Kaplan EH, Rosen ST, Norris DB, Roenigk HH, Saks SR, Bunn PA. Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst. 1990 Feb 07; 82(3):208-12. PMID: 2104937.
      View in: PubMed
    288. Kuzel TM, Gilyon K, Springer E, Variakojis D, Kaul K, Bunn PA, Evans L, Roenigk HH, Rosen ST. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst. 1990 Feb 07; 82(3):203-7. PMID: 2296050.
      View in: PubMed
    289. Kohn EC, Steis RG, Sausville EA, Veach SR, Stocker JL, Phelps R, Franco S, Longo DL, Bunn PA, Ihde DC. Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome. J Clin Oncol. 1990 Jan; 8(1):155-60. PMID: 2295906.
      View in: PubMed
    290. Kaye FJ, Bunn PA, Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, Glatstein EJ, Schechter GP, Phelps RM, Foss FM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med. 1989 Dec 28; 321(26):1784-90. PMID: 2594037.
      View in: PubMed
    291. Bunn PA. The expanding role of cisplatin in the treatment of non-small-cell lung cancer. Semin Oncol. 1989 Aug; 16(4 Suppl 6):10-21. PMID: 2548280.
      View in: PubMed
    292. Graham ML, Bunn PA, Jewett PB, Gonzalez-Aller C, Horwitz KB. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines. Cancer Res. 1989 Jul 15; 49(14):3934-42. PMID: 2736533.
      View in: PubMed
    293. Bunn PA. HTLV-I-associated diseases. West J Med. 1989 May; 150(5):578-9. PMID: 2741453.
      View in: PubMed
    294. Bunn PA. Review of therapeutic trials of carboplatin in lung cancer. Semin Oncol. 1989 Apr; 16(2 Suppl 5):27-33. PMID: 2541506.
      View in: PubMed
    295. Bunn PA. Diagnostic factors in intermediate and high-grade lymphomas: pathologic, immunologic, and clinical. J Clin Oncol. 1988 Jul; 6(7):1073-5. PMID: 2899139.
      View in: PubMed
    296. Beck LK, Kane MA, Bunn PA. Innovative and future approaches to small cell lung cancer treatment. Semin Oncol. 1988 Jun; 15(3):300-14. PMID: 2454512.
      View in: PubMed
    297. Carmichael J, Crane JM, Bunn PA, Glatstein E, Ihde DC. Results of therapeutic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys. 1988 Mar; 14(3):455-9. PMID: 2830211.
      View in: PubMed
    298. Roth MS, Bunn PA, Foon KA. Interferon therapy for lymphoproliferative disorders. Cancer Treat Res. 1988; 38:231-52. PMID: 2484433.
      View in: PubMed
    299. Keenan AM, Weinstein JN, Carrasquillo JA, Bunn PA, Reynolds JC, Foon KA, Smarte NC, Ghosh B, Fejka RM, Larson SM, et al. Immunolymphoscintigraphy and the dose dependence of 111In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphoma. Cancer Res. 1987 Nov 15; 47(22):6093-9. PMID: 3499222.
      View in: PubMed
    300. Doyle LA, Cuttitta F, Mulshine JL, Bunn PA, Minna JD. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells. Cancer Res. 1987 Oct 01; 47(19):5009-13. PMID: 3040237.
      View in: PubMed
    301. Mulshine JL, Keenan AM, Carrasquillo JA, Walsh T, Linnoila RI, Holton OD, Harwell J, Larson SM, Bunn PA, Weinstein JN. Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes in dogs: a new approach to lung cancer imaging. Cancer Res. 1987 Jul 01; 47(13):3572-6. PMID: 3472655.
      View in: PubMed
    302. Bunn PA, Lichter AS, Makuch RW, Cohen MH, Veach SR, Matthews MJ, Anderson AJ, Edison M, Glatstein E, Minna JD, et al. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. Ann Intern Med. 1987 May; 106(5):655-62. PMID: 3032033.
      View in: PubMed
    303. Carrasquillo JA, Mulshine JL, Bunn PA, Reynolds JC, Foon KA, Schroff RW, Perentesis P, Steis RG, Keenan AM, Horowitz M, et al. Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma. J Nucl Med. 1987 Mar; 28(3):281-7. PMID: 3102699.
      View in: PubMed
    304. Foon KA, Roth MS, Bunn PA. Interferon therapy of non-Hodgkin's lymphoma. Cancer. 1987 Feb 01; 59(3 Suppl):601-4. PMID: 3492259.
      View in: PubMed
    305. Dmitrovsky E, Matthews MJ, Bunn PA, Schechter GP, Makuch RW, Winkler CF, Eddy J, Sausville EA, Ihde DC. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol. 1987 Feb; 5(2):208-15. PMID: 3492594.
      View in: PubMed
    306. Keenan AM, Weinstein JN, Mulshine JL, Carrasquillo JA, Bunn PA, Reynolds JC, Larson SM. Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibody. J Nucl Med. 1987 Jan; 28(1):42-6. PMID: 3794811.
      View in: PubMed
    307. Bunn PA, Ihde DC, Foon KA. Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas. Int J Cancer Suppl. 1987; 1:9-13. PMID: 3305390.
      View in: PubMed
    308. Foon KA, Bunn PA. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia. Semin Oncol. 1986 Dec; 13(4 Suppl 5):35-9. PMID: 3541217.
      View in: PubMed
    309. Pedersen AG, Becker KL, Bach F, Snider RH, Gazdar AF, Sorensen PS, Bunn PA, Hansen HH. Cerebrospinal fluid bombesin and calcitonin in patients with central nervous system metastases from small-cell lung cancer. J Clin Oncol. 1986 Nov; 4(11):1620-7. PMID: 3021922.
      View in: PubMed
    310. Dodd RC, Winkler CF, Williams ME, Bunn PA, Gray TK. Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma. Arch Intern Med. 1986 Oct; 146(10):1971-2. PMID: 2876692.
      View in: PubMed
    311. Funa K, Dawson N, Jewett PB, Agren H, Ruckdeschel JC, Bunn PA, Gazdar AF. Automated fluorescent analysis for drug-induced cytotoxicity assays. Cancer Treat Rep. 1986 Oct; 70(10):1147-51. PMID: 3019545.
      View in: PubMed
    312. Ihde DC, Deisseroth AB, Lichter AS, Bunn PA, Carney DN, Cohen MH, Veach SR, Makuch RW, Johnston-Early A, Abrams RA, et al. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol. 1986 Oct; 4(10):1443-54. PMID: 3020181.
      View in: PubMed
    313. Carrasquillo JA, Bunn PA, Keenan AM, Reynolds JC, Schroff RW, Foon KA, Su MH, Gazdar AF, Mulshine JL, Oldham RK, et al. Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody. N Engl J Med. 1986 Sep 11; 315(11):673-80. PMID: 3489185.
      View in: PubMed
    314. Foon KA, Roth MS, Bunn PA. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):35-42. PMID: 3532334.
      View in: PubMed
    315. Seifter EJ, Bunn PA, Cohen MH, Makuch RW, Dunnick NR, Javadpour N, Bensimon H, Eddy JL, Minna JD, Ihde DC. A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate. J Clin Oncol. 1986 Sep; 4(9):1365-73. PMID: 2943877.
      View in: PubMed
    316. Bunn PA, Greco FA, Einhorn L. Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer. Semin Oncol. 1986 Sep; 13(3 Suppl 3):45-53. PMID: 3020700.
      View in: PubMed
    317. Kuefler PR, Bunn PA. Adult T cell leukaemia/lymphoma. Clin Haematol. 1986 Aug; 15(3):695-726. PMID: 2877762.
      View in: PubMed
    318. Batist G, Carney DN, Cowan KH, Veach SR, Gilliom M, Bunn PA, Ihde DC. Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates. J Clin Oncol. 1986 Jun; 4(6):982-6. PMID: 3012008.
      View in: PubMed
    319. Johnson BE, Ihde DC, Matthews MJ, Bunn PA, Zabell A, Makuch RW, Johnston-Early A, Cohen MH, Glatstein E, Minna JD. Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer. Am J Med. 1986 Jun; 80(6):1103-10. PMID: 3014875.
      View in: PubMed
    320. Fargion S, Carney D, Mulshine J, Rosen S, Bunn P, Jewett P, Cuttitta F, Gazdar A, Minna J. Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. Cancer Res. 1986 May; 46(5):2633-8. PMID: 3008997.
      View in: PubMed
    321. Bunn PA, Ihde DC, Foon KA. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas. Cancer. 1986 Apr 15; 57(8 Suppl):1689-95. PMID: 3485012.
      View in: PubMed
    322. Brooks BJ, Seifter EJ, Walsh TE, Lichter AS, Bunn PA, Zabell A, Johnston-Early A, Edison M, Makuch RW, Cohen MH, et al. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. J Clin Oncol. 1986 Feb; 4(2):200-9. PMID: 3003259.
      View in: PubMed
    323. Boven E, Lindmo T, Mitchell JB, Bunn PA. Selective cytotoxicity of 125I-labeled monoclonal antibody T101 in human malignant T cell lines. Blood. 1986 Feb; 67(2):429-35. PMID: 2417645.
      View in: PubMed
    324. Foon KA, Schroff RW, Bunn PA. Clinical applications of monoclonal antibodies for patients with leukemia and lymphoma. Prog Clin Biol Res. 1986; 211:265-84. PMID: 3515361.
      View in: PubMed
    325. Lindmo T, Bunn PA. Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling. Methods Enzymol. 1986; 121:678-91. PMID: 3523136.
      View in: PubMed
    326. Bunn PA, Foon KA. Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A). Semin Oncol. 1985 Dec; 12(4 Suppl 5):18-24. PMID: 3878594.
      View in: PubMed
    327. Sausville EA, Worsham GF, Matthews MJ, Makuch RW, Fischmann AB, Schechter GP, Gazdar AF, Bunn PA. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. Hum Pathol. 1985 Nov; 16(11):1098-109. PMID: 3876976.
      View in: PubMed
    328. Lindmo T, Boven E, Mitchell JB, Morstyn G, Bunn PA. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody. Cancer Res. 1985 Oct; 45(10):5080-7. PMID: 4027987.
      View in: PubMed
    329. Johnson BE, Ihde DC, Bunn PA, Becker B, Walsh T, Weinstein ZR, Matthews MJ, Whang-Peng J, Makuch RW, Johnston-Early A, et al. Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up. Ann Intern Med. 1985 Sep; 103(3):430-8. PMID: 2992337.
      View in: PubMed
    330. Sidi Y, Edwards NL, Winkler C, Bunn P, Mitchell BS. Differential metabolism of deoxyribonucleosides by leukaemic T cells of immature and mature phenotype. Br J Haematol. 1985 Sep; 61(1):125-34. PMID: 2996581.
      View in: PubMed
    331. Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PA. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985 Aug 29; 313(9):534-8. PMID: 3875035.
      View in: PubMed
    332. Gazdar AF, Bunn PA, Minna JD, Baylin SB. Origin of human small cell lung cancer. Science. 1985 Aug 16; 229(4714):679-80. PMID: 2992083.
      View in: PubMed
    333. Dodd RC, Newman SL, Bunn PA, Winkler CF, Cohen MS, Gray TK. Lymphokine-induced monocytic differentiation as a possible mechanism for hypercalcemia associated with adult T-cell lymphoma. Cancer Res. 1985 Jun; 45(6):2501-6. PMID: 2580622.
      View in: PubMed
    334. Doyle A, Martin WJ, Funa K, Gazdar A, Carney D, Martin SE, Linnoila I, Cuttitta F, Mulshine J, Bunn P, et al. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med. 1985 May 01; 161(5):1135-51. PMID: 2580935.
      View in: PubMed
    335. Lichter AS, Bunn PA, Ihde DC, Cohen MH, Makuch RW, Carney DN, Johnston-Early A, Minna JD, Glatstein E. The role of radiation therapy in the treatment of small cell lung cancer. Cancer. 1985 May 01; 55(9 Suppl):2163-75. PMID: 2983875.
      View in: PubMed
    336. Bunn PA, Linnoila I, Minna JD, Carney D, Gazdar AF. Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express the Leu-7 antigenic determinant present on natural killer cells. Blood. 1985 Mar; 65(3):764-8. PMID: 2578840.
      View in: PubMed
    337. Rosen ST, Radvany R, Roenigk H, Terasaki PI, Bunn PA. Human leukocyte antigens in cutaneous T cell lymphoma. J Am Acad Dermatol. 1985 Mar; 12(3):531-4. PMID: 3872893.
      View in: PubMed
    338. Whang-Peng J, Bunn PA, Knutsen T, Kao-Shan CS, Broder S, Jaffe ES, Gelmann E, Blattner W, Lofters W, Young RC, et al. Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States. J Natl Cancer Inst. 1985 Feb; 74(2):357-69. PMID: 2983135.
      View in: PubMed
    339. Doyle LA, Ihde DC, Carney DN, Bunn PA, Cohen MH, Matthews MJ, Puffenbarger R, Cordes RS, Minna JD. Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin C. Am J Clin Oncol. 1984 Dec; 7(6):719-24. PMID: 6442103.
      View in: PubMed
    340. Morstyn G, Schechter GP, Ihde DC, Carney DN, Eddy JL, Cohen MH, Minna JD, Bunn PA. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness. Cancer Treat Rep. 1984 Dec; 68(12):1439-46. PMID: 6391662.
      View in: PubMed
    341. Bunn PA, Carrasquillo JA, Keenan AM, Schroff RW, Foon KA, Hsu SM, Gazdar AF, Reynolds JC, Perentesis P, Larson SM. Imaging of T-cell lymphoma by radiolabelled monoclonal antibody. Lancet. 1984 Nov 24; 2(8413):1219-21. PMID: 6150269.
      View in: PubMed
    342. Foon KA, Schroff RW, Bunn PA, Mayer D, Abrams PG, Fer M, Ochs J, Bottino GC, Sherwin SA, Carlo DJ, et al. Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia. Blood. 1984 Nov; 64(5):1085-93. PMID: 6333257.
      View in: PubMed
    343. Bunn PA, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeffren J, Sherwin S, Oldham R. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med. 1984 Oct; 101(4):484-7. PMID: 6332565.
      View in: PubMed
    344. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods. 1984 Aug 03; 72(1):77-89. PMID: 6086763.
      View in: PubMed
    345. Broder S, Bunn PA, Jaffe ES, Blattner W, Gallo RC, Wong-Staal F, Waldmann TA, DeVita VT. NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med. 1984 Apr; 100(4):543-57. PMID: 6322632.
      View in: PubMed
    346. Jaffe ES, Blattner WA, Blayney DW, Bunn PA, Cossman J, Robert-Guroff M, Gallo RC. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virus-associated lymphoid malignancies. Am J Surg Pathol. 1984 Apr; 8(4):263-75. PMID: 6324600.
      View in: PubMed
    347. Morstyn G, Ihde DC, Lichter AS, Bunn PA, Carney DN, Glatstein E, Minna JD. Small cell lung cancer 1973-1983: early progress and recent obstacles. Int J Radiat Oncol Biol Phys. 1984 Apr; 10(4):515-39. PMID: 6327578.
      View in: PubMed
    348. Schüpbach J, Kalyanaraman VS, Sarngadharan MG, Bunn PA, Blayney DW, Gallo RC. Demonstration of viral antigen p24 in circulating immune complexes of two patients with human T-cell leukaemia/lymphoma virus (HTLV) positive lymphoma. Lancet. 1984 Feb 11; 1(8372):302-5. PMID: 6141379.
      View in: PubMed
    349. Averbuch SD, Austin HA, Sherwin SA, Antonovych T, Bunn PA, Longo DL. Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides. N Engl J Med. 1984 Jan 05; 310(1):32-5. PMID: 6689738.
      View in: PubMed
    350. Brower M, Ihde DC, Johnston-Early A, Bunn PA, Cohen MH, Carney DN, Makuch RW, Matthews MJ, Radice PA, Minna JD. Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy. Am J Med. 1983 Dec; 75(6):993-1000. PMID: 6316784.
      View in: PubMed
    351. Brower M, Carney DN, Ihde DC, Eddy J, Bunn PA, Cohen MH, Pelsor FR, Matthews MJ, Minna JD. High-dose methotrexate with leucovorin rescue in patients with unresectable non-small cell carcinoma of the lung. Cancer. 1983 Nov 15; 52(10):1778-82. PMID: 6605186.
      View in: PubMed
    352. Johnston-Early A, Cohen MH, Fossieck BE, Harwood S, Ihde DC, Bunn PA, Matthews MJ, Minna JD, Makuch R. Delayed hypersensitivity skin testing as a prognostic indicator in patients with small cell lung cancer. Cancer. 1983 Oct 15; 52(8):1395-400. PMID: 6311393.
      View in: PubMed
    353. Bunn PA, Carney DN, Gazdar AF, Whang-Peng J, Matthews MJ. Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. Cancer Res. 1983 Oct; 43(10):5026-32. PMID: 6883349.
      View in: PubMed
    354. Morstyn G, Ihde DC, Eddy JL, Bunn PA, Cohen MH, Minna JD. Combination chemotherapy of hepatocellular carcinoma with doxorubicin and streptozotocin. Am J Clin Oncol. 1983 Oct; 6(5):547-51. PMID: 6310986.
      View in: PubMed
    355. Mitsuya H, Matis LA, Megson M, Bunn PA, Murray C, Mann DL, Gallo RC, Broder S. Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus. J Exp Med. 1983 Sep 01; 158(3):994-9. PMID: 6604130.
      View in: PubMed
    356. Blayney DW, Blattner WA, Robert-Guroff M, Jaffe ES, Fisher RI, Bunn PA, Patton MG, Rarick HR, Gallo RC. The human T-cell leukemia-lymphoma virus in the southeastern United States. JAMA. 1983 Aug 26; 250(8):1048-52. PMID: 6308290.
      View in: PubMed
    357. Bunn PA, Schechter GP, Jaffe E, Blayney D, Young RC, Matthews MJ, Blattner W, Broder S, Robert-Guroff M, Gallo RC. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med. 1983 Aug 04; 309(5):257-64. PMID: 6602943.
      View in: PubMed
    358. Blayney DW, Jaffe ES, Blattner WA, Cossman J, Robert-Guroff M, Longo DL, Bunn PA, Gallo RC. The human T-cell leukemia/lymphoma virus associated with American adult T-cell leukemia/lymphoma. Blood. 1983 Aug; 62(2):401-5. PMID: 6223675.
      View in: PubMed
    359. Gallo RC, Kalyanaraman VS, Sarngadharan MG, Sliski A, Vonderheid EC, Maeda M, Nakao Y, Yamada K, Ito Y, Gutensohn N, Murphy S, Bunn PA, Catovsky D, Greaves MF, Blayney DW, Blattner W, Jarrett WF, zur Hausen H, Seligmann M, Brouet JC, Haynes BF, Jegasothy BV, Jaffe E, Cossman J, Broder S, Fisher RI, Golde DW, Robert-Guroff M. Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res. 1983 Aug; 43(8):3892-9. PMID: 6602653.
      View in: PubMed
    360. Rosen ST, Makuch RW, Lichter AS, Ihde DC, Matthews MJ, Minna JD, Glatstein E, Bunn PA. Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer. Potential benefit restricted to patients with complete response. Am J Med. 1983 Apr; 74(4):615-24. PMID: 6301274.
      View in: PubMed
    361. Batist G, Ihde DC, Zabell A, Lichter AS, Veach SR, Cohen MH, Carney DN, Bunn PA. Small-cell carcinoma of lung: reinduction therapy after late relapse. Ann Intern Med. 1983 Apr; 98(4):472-4. PMID: 6301321.
      View in: PubMed
    362. Winkler CF, Bunn PA. Cutaneous T-cell lymphoma: a review. Crit Rev Oncol Hematol. 1983; 1(1):49-92. PMID: 6083835.
      View in: PubMed
    363. Robert-Guroff M, Kalyanaraman VS, Blattner WA, Popovic M, Sarngadharan MG, Maeda M, Blayney D, Catovsky D, Bunn PA, Shibata A, Nakao Y, Ito Y, Aoki T, Gallo RC. Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients. J Exp Med. 1983 Jan 01; 157(1):248-58. PMID: 6600268.
      View in: PubMed
    364. Bleehen NM, Bunn PA, Cox JD, Dombernowsky P, Fox RM, Høst H, Joss R, White JE, Wittes RE. Role of radiation therapy in small cell anaplastic carcinoma of the lung. Cancer Treat Rep. 1983 Jan; 67(1):11-9. PMID: 6193877.
      View in: PubMed
    365. Radice PA, Matthews MJ, Ihde DC, Gazdar AF, Carney DN, Bunn PA, Cohen MH, Fossieck BE, Makuch RW, Minna JD. The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer. 1982 Dec 15; 50(12):2894-902. PMID: 6291745.
      View in: PubMed
    366. Krasnow S, Bunn PA, Ihde DC, Matthews MJ, Cohen MH, Eddy J, Minna JD. ICRF-159 in advanced gastric cancer. Absence of activity. Am J Clin Oncol. 1982 Dec; 5(6):635-9. PMID: 7165006.
      View in: PubMed
    367. Munson D, Bunn PA, Schechter GP. Fc receptor-defined T-lymphocyte subpopulations in patients with cutaneous T-cell lymphoma. J Invest Dermatol. 1982 Nov; 79(5):317-21. PMID: 6982301.
      View in: PubMed
    368. Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer. 1982 Oct 15; 50(8):1539-53. PMID: 6981450.
      View in: PubMed
    369. Blatt J, Bunn PA, Carney DD, Reaman G, Soprey P, Poplack DG. Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T-cell lymphoma. Br J Haematol. 1982 Sep; 52(1):97-104. PMID: 6288063.
      View in: PubMed
    370. Brigham BA, Bunn PA, Horton JE, Schechter GP, Wahl LM, Bradley EC, Dunnick NR, Matthews MJ. Skeletal manifestations in cutaneous T-cell lymphomas. Arch Dermatol. 1982 Jul; 118(7):461-7. PMID: 6979976.
      View in: PubMed
    371. Whang-Peng J, Bunn PA, Kao-Shan CS, Lee EC, Carney DN, Gazdar A, Minna JD. A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet. 1982 Jun; 6(2):119-34. PMID: 6286098.
      View in: PubMed
    372. Ihde DC, Johnston-Early A, Carney DN, Cohen MH, Bunn PA, Pelsor FR, Minna JD. Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung. Cancer Treat Rep. 1982 May; 66(5):1223-5. PMID: 6282453.
      View in: PubMed
    373. Ihde DC, Dunnick NR, Johnston-Early A, Bunn PA, Cohen MH, Minna JD. Abdominal computed tomography in small cell lung cancer: assessment of extent of disease and response to therapy. Cancer. 1982 Apr 01; 49(7):1485-90. PMID: 6277467.
      View in: PubMed
    374. Carney DN, Marangos PJ, Ihde DC, Bunn PA, Cohen MH, Minna JD, Gazdar AF. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet. 1982 Mar 13; 1(8272):583-5. PMID: 6121182.
      View in: PubMed
    375. Thant M, Hawley RJ, Smith MT, Cohen MH, Minna JD, Bunn PA, Ihde DC, West W, Matthews MJ. Possible enhancement of vincristine neuropathy by VP-16. Cancer. 1982 Mar 01; 49(5):859-64. PMID: 6277454.
      View in: PubMed
    376. Bunn PA, Krasnow S, Makuch RW, Schlam ML, Schechter GP. Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications. Blood. 1982 Mar; 59(3):528-35. PMID: 6800416.
      View in: PubMed
    377. Bradley EC, Schechter GP, Matthews MJ, Whang-Peng J, Cohen MH, Bunn PA, Ihde DC, Minna JD. Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer. Cancer. 1982 Jan 15; 49(2):221-3. PMID: 6274504.
      View in: PubMed
    378. Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF, Minna JD. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science. 1982 Jan 08; 215(4529):181-2. PMID: 6274023.
      View in: PubMed
    379. Minna JD, Bunn PA, Carney DN, Cohen MH, Cuttita F, Fosieck BE, Gazdar AF, Ihde DC, Johnston-Early A, Matthews MJ, Makuch R, Oie H, Rosen S, Lichter A, Glatstein E. Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer. Bull Cancer. 1982; 69(1):83-93. PMID: 6280795.
      View in: PubMed
    380. Rosen ST, Aisner J, Makuch RW, Matthews MJ, Ihde DC, Whitacre M, Glatstein EJ, Wiernik PH, Lichter AS, Bunn PA. Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Medicine (Baltimore). 1982 Jan; 61(1):45-53. PMID: 6276648.
      View in: PubMed
    381. Carney DN, Gazdar AF, Bunn PA, Guccion JG. Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients. Stem Cells. 1982; 1(3):149-64. PMID: 6294885.
      View in: PubMed
    382. Minna JD, Cuttitta F, Rosen S, Bunn PA, Carney DN, Gazdar AF, Krasnow S. Methods for production of monoclonal antibodies with specificity for human lung cancer cells. In Vitro. 1981 Dec; 17(12):1058-70. PMID: 6172365.
      View in: PubMed
    383. Earle MF, Fossieck BE, Cohen MH, Ihde DC, Bunn PA, Minna JD. Perirectal infections in patients with small cell lung cancer. JAMA. 1981 Nov 27; 246(21):2464-6. PMID: 6271992.
      View in: PubMed
    384. Kalyanaraman VS, Sarngadharan MG, Bunn PA, Minna JD, Gallo RC. Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus. Nature. 1981 Nov 19; 294(5838):271-3. PMID: 6272126.
      View in: PubMed
    385. Levenson RM, Ihde DC, Matthews MJ, Cohen MH, Gazdar AF, Bunn PA, Minna JD. Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy. J Natl Cancer Inst. 1981 Sep; 67(3):607-12. PMID: 6268879.
      View in: PubMed
    386. Levenson RM, Ihde DC, Huberman MS, Cohen MH, Bunn PA, Minna JD. Phase II trial of cisplatin in small cell carcinoma of the lung. Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):905-7. PMID: 6268297.
      View in: PubMed
    387. Posner LE, Robert-Guroff M, Kalyanaraman VS, Poiesz BJ, Ruscetti FW, Fossieck B, Bunn PA, Minna JD, Gallo RC. Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. J Exp Med. 1981 Aug 01; 154(2):333-46. PMID: 6973601.
      View in: PubMed
    388. Posner LE, Fossieck BE, Eddy JL, Bunn PA. Septicemic complications of the cutaneous T-cell lymphomas. Am J Med. 1981 Aug; 71(2):210-6. PMID: 6973273.
      View in: PubMed
    389. Levenson RM, Sauerbrunn BJ, Ihde DC, Bunn PA, Cohen MH, Minna JD. Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response. AJR Am J Roentgenol. 1981 Jul; 137(1):31-5. PMID: 6264774.
      View in: PubMed
    390. Haynes BF, Metzgar RS, Minna JD, Bunn PA. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981 May 28; 304(22):1319-23. PMID: 6971410.
      View in: PubMed
    391. Carney DN, Bunn PA, Gazdar AF, Pagan JA, Minna JD. Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc Natl Acad Sci U S A. 1981 May; 78(5):3185-9. PMID: 6265940.
      View in: PubMed
    392. Ihde DC, Makuch RW, Carney DN, Bunn PA, Cohen MH, Matthews MJ, Minna JD. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis. 1981 May; 123(5):500-7. PMID: 6263137.
      View in: PubMed
    393. Bunn PA, Edelson R, Ford SS, Shackney SE. Patterns of cell proliferation and cell migration in the Sézary syndrome. Blood. 1981 Mar; 57(3):452-63. PMID: 6970051.
      View in: PubMed
    394. Cohen MH, Makuch R, Johnston-Early A, Ihde DC, Bunn PA, Fossieck BE, Minna JD. Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treat Rep. 1981 Mar-Apr; 65(3-4):187-95. PMID: 6263468.
      View in: PubMed
    395. Haynes BF, Bunn P, Mann D, Thomas C, Eisenbarth GS, Minna J, Fauci AS. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. J Clin Invest. 1981 Feb; 67(2):523-30. PMID: 6970206.
      View in: PubMed
    396. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec; 77(12):7415-9. PMID: 6261256.
      View in: PubMed
    397. Carney DN, Matthews MJ, Ihde DC, Bunn PA, Cohen MH, Makuch RW, Gazdar AF, Minna JD. Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival. J Natl Cancer Inst. 1980 Dec; 65(6):1225-30. PMID: 6253711.
      View in: PubMed
    398. Carney DN, Bunn PA, Schechter GP, Gazdar AF. Lymphocyte transformation in patients with cutaneous T-cell lymphomas. Int J Cancer. 1980 Nov 15; 26(5):535-42. PMID: 6972355.
      View in: PubMed
    399. Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck BE, Ihde DC, Bunn PA, Matthews MJ, Makuch R. Smoking abstinence and small cell lung cancer survival. An association. JAMA. 1980 Nov 14; 244(19):2175-9. PMID: 6252357.
      View in: PubMed
    400. Gazdar AF, Carney DN, Russell EK, Sims HL, Baylin SB, Bunn PA, Guccion JG, Minna JD. Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res. 1980 Oct; 40(10):3502-7. PMID: 6108156.
      View in: PubMed
    401. Broder S, Bunn PA. Cutaneous T-cell lymphomas. Semin Oncol. 1980 Sep; 7(3):310-31. PMID: 6447914.
      View in: PubMed
    402. Carney DN, Bunn PA. Benign and malignant monoclonal gammopathies. Prim Care. 1980 Sep; 7(3):369-94. PMID: 6777792.
      View in: PubMed
    403. Bunn PA, Huberman MS, Whang-Peng J, Schechter GP, Guccion JG, Matthews MJ, Gazdar AF, Dunnick NR, Fischmann AB, Ihde DC, Cohen MH, Fossieck B, Minna JD. Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med. 1980 Aug; 93(2):223-30. PMID: 6967710.
      View in: PubMed
    404. Levine RF, Bunn PA, Hazzard KC, Schlam ML. Flow cytometric analysis of megakaryocyte ploidy. Comparison with Feulgen microdensitometry and discovery that 8N is the predominant ploidy class in guinea pig and monkey marrow. Blood. 1980 Aug; 56(2):210-17. PMID: 6772262.
      View in: PubMed
    405. Bunn PA, Whang-Peng J, Carney DN, Schlam ML, Knutsen T, Gazdar AF. DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest. 1980 Jun; 65(6):1440-8. PMID: 6997334.
      View in: PubMed
    406. Myrie C, Bunn PA, Edelson RL. A clinico-histopathologic atlas. J Dermatol Surg Oncol. 1980 May; 6(5):391-400. PMID: 6445914.
      View in: PubMed
    407. Carney DN, Bunn PA. Manifestations of cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May; 6(5):369-77. PMID: 6966639.
      View in: PubMed
    408. Bunn PA, Carney DN. Treatment of cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May; 6(5):383-7. PMID: 6769987.
      View in: PubMed
    409. Huberman MS, Bunn PA, Matthews MJ, Ihde DC, Gazdar AF, Cohen MH, Minna JD. Hepatic involvement in the cutaneous T-cell lymphomas: results of percutaneous biopsy and peritoneoscopy. Cancer. 1980 Apr 01; 45(7):1683-8. PMID: 6445224.
      View in: PubMed
    410. Ihde DC, Cohen MH, Simms EB, Matthews MJ, Bunn PA, Minna JD. Evaluation of response to chemotherapy with fiberoptic bronchoscopy in non-small cell lung cancer. Cancer. 1980 Apr 01; 45(7):1693-6. PMID: 6245782.
      View in: PubMed
    411. Ihde DC, Bunn PA, Cohen MH, Dunnick NR, Eddy JL, Minna JD. Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide: methods of documenting tumor response and progression. Cancer. 1980 Mar 15; 45(6):1300-10. PMID: 7357521.
      View in: PubMed
    412. Shackney SE, Bunn PA, Ford SS, Erickson B, Ross WE, Levine AS. A study of drug-induced kinetic perturbations in the marrow of a patient with neuroblastoma. Cancer. 1980 Mar 01; 45(5):882-92. PMID: 7260840.
      View in: PubMed
    413. Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, Guccion JG. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 1980 Mar; 55(3):409-17. PMID: 6244013.
      View in: PubMed
    414. Huberman M, Fossieck BE, Bunn PA, Cohen MH, Ihde DC, Minna JD. Herpes zoster and small cell bronchogenic carcinoma. Am J Med. 1980 Feb; 68(2):214-8. PMID: 6243858.
      View in: PubMed
    415. Nugent JL, Bunn PA, Matthews MJ, Ihde DC, Cohen MH, Gazdar A, Minna JD. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer. 1979 Nov; 44(5):1885-93. PMID: 227582.
      View in: PubMed
    416. Lamberg SI, Bunn PA. Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop. Arch Dermatol. 1979 Sep; 115(9):1103-5. PMID: 39515.
      View in: PubMed
    417. Ihde DC, Bilek FS, Cohen MH, Bunn PA, Eddy J, Minna JD. Response to thoracic radiotherapy in patients with small cell carcinoma of the lung after failure of combination chemotherapy. Radiology. 1979 Aug; 132(2):443-6. PMID: 223196.
      View in: PubMed
    418. Radice PA, Bunn PA, Ihde DC. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies. Cancer Treat Rep. 1979 Aug; 63(8):1231-9. PMID: 225026.
      View in: PubMed
    419. Cohen MH, Chretien PB, Ihde DC, Fossieck BE, Makuch R, Bunn PA, Johnston AV, Shackney SE, Matthews MJ, Lipson SD, Kenady DE, Minna JD. Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer. JAMA. 1979 Apr 27; 241(17):1813-5. PMID: 219267.
      View in: PubMed
    420. Bunn PA, Lamberg SI. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):725-8. PMID: 445521.
      View in: PubMed
    421. Bunn PA, Fischmann AB, Schechter GP, Kumar PP, Ihde DC, Cohen MH, Fossieck BE, Gazdar AF, Matthews MJ, Eddy JL, Minna JD. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):713-7. PMID: 109208.
      View in: PubMed
    422. Shackney SE, Edelson R, Bunn PA. The kinetics of Sézary cell production. Cancer Treat Rep. 1979 Apr; 63(4):659-61. PMID: 445517.
      View in: PubMed
    423. Bunn PA, Cohen MI, Widerlite L, Nugent JL, Matthews MJ, Minna JD. Simultaneous gastric and plasma immunoreactive plasma carcinoembryonic antigen in 108 patients undergoing gastroscopy. Gastroenterology. 1979 Apr; 76(4):734-41. PMID: 422001.
      View in: PubMed
    424. Whang-Peng J, Bunn P, Knutsen T, Schechter GP, Gazdar AF, Matthews MJ, Minna JD. Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):575-80. PMID: 312695.
      View in: PubMed
    425. Gazdar AF, Carney DN, Russell EK, Schechter GP, Bunn PA. In vitro growth of cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):587-90. PMID: 221120.
      View in: PubMed
    426. Lamberg SI, Bunn PA. Proceedings of the Workshop on Cutaneous T-Cell Lymphomas (Mycosis Fungoides and Sézary Syndrome). Introduction. Cancer Treat Rep. 1979 Apr; 63(4):561-4. PMID: 376139.
      View in: PubMed
    427. Guccion JG, Fischmann AB, Bunn PA, Schechter GP, Patterson RH, Matthews MJ. Ultrastructural appearance of cutaneous T cell lymphomas in skin, lymph nodes, and peripheral blood. Cancer Treat Rep. 1979 Apr; 63(4):565-70. PMID: 312693.
      View in: PubMed
    428. Fischmann AB, Bunn PA, Guccion JG, Matthews MJ, Minna JD. Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sézary syndrome. Cancer Treat Rep. 1979 Apr; 63(4):591-6. PMID: 445514.
      View in: PubMed
    429. Schechter GP, Bunn PA, Fischmann AB, Matthews MJ, Guccion J, Soehnlen F, Munson D, Minna JD. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy. Cancer Treat Rep. 1979 Apr; 63(4):571-4. PMID: 312694.
      View in: PubMed
    430. Ihde DC, Simms EB, Matthews MJ, Cohen MH, Bunn PA, Minna JD. Bone marrow metastases in small cell carcinoma of the lung: frequency, description, and influence on chemotherapeutic toxicity and prognosis. Blood. 1979 Apr; 53(4):677-86. PMID: 218597.
      View in: PubMed
    431. Cohen MH, Ihde DC, Bunn PA, Fossieck BE, Matthews MJ, Shackney SE, Johnston-Early A, Makuch R, Minna JD. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep. 1979 Feb; 63(2):163-70. PMID: 221114.
      View in: PubMed
    432. Brigham BA, Bunn PA, Minna JD, Cohen MH, Ihde DC, Shackney SE. Growth rates of small cell bronchogenic carcinomas. Cancer. 1978 Dec; 42(6):2880-6. PMID: 215299.
      View in: PubMed
    433. Ihde DC, Cohen MH, Bernath AM, Matthews MJ, Bunn PA, Minna JD. Serial fiberoptic bronchoscopy during chemotherapy for small cell carcinoma of the lung: early detection of patients at high risk of relapse. Chest. 1978 Nov; 74(5):531-6. PMID: 216531.
      View in: PubMed
    434. Bunn PA, Nugent JL, Ihde DC, Cohen MH, Eddy JL, Minna JD. 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer. Cancer Treat Rep. 1978 Sep; 62(9):1287-93. PMID: 356983.
      View in: PubMed
    435. Bunn PA, Nugent JL, Matthews MJ. Central nervous system metastases in small cell bronchogenic carcinoma. Semin Oncol. 1978 Sep; 5(3):314-22. PMID: 211643.
      View in: PubMed
    436. Cohen MH, Bunn PA, Ihde DC, Fossieck BE, Minna JD. Chemotherapy rather than demeclocycline for inappropriate secretion of antidiuretic hormone. N Engl J Med. 1978 Jun 22; 298(25):1423-4. PMID: 206831.
      View in: PubMed
    437. Bunn PA, Ihde DC, Cohen MH, Shackney SE, Minna JD. Streptozotocin in advanced small cell bronchogenic carcinoma: an ineffective nonmyelosuppressive agent. Cancer Treat Rep. 1978 Mar; 62(3):479-81. PMID: 148321.
      View in: PubMed
    438. Ihde DC, Cohen MH, Bunn PA, Bernath AM, Broder LE, Minna JD. Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity. Cancer Treat Rep. 1978 Jan; 62(1):155-7. PMID: 75065.
      View in: PubMed
    439. Bunn PA, Ford SS, Shackney SE. Rapid grain and cell counting for cell kinetic studies. J Natl Cancer Inst. 1977 Jul; 59(1):285-7. PMID: 69033.
      View in: PubMed
    440. Bunn PA, Cohen MH, Ihde DC, Fossieck BE, Matthews MJ, Minna JD. Advances in small cell bronchogenic carcinoma. Cancer Treat Rep. 1977 May-Jun; 61(3):333-42. PMID: 194690.
      View in: PubMed
    441. Bunn PA, Shackney SE, Ford SS. The effects of colcemid on hematopoiesis in the mouse. J Clin Invest. 1976 Nov; 58(5):1280-5. PMID: 993346.
      View in: PubMed
    442. Shackney SE, Bunn PA, Ford SS. The effects of colcemid on mouse bone marrow. Cell Tissue Kinet. 1976 Jul; 9(4):363-9. PMID: 1277267.
      View in: PubMed
    443. Bunn PA, Schein PS, Banks PM, DeVita VT. Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. Blood. 1976 Jan; 47(1):3-10. PMID: 1106798.
      View in: PubMed
    444. Richman SD, Levenson SM, Bunn PA, Flinn GS, Johnston GS, DeVita VT. 67Ga accumulation in pulmonary lesions associated with bleomycin toxicity. Cancer. 1975 Dec; 36(6):1966-72. PMID: 54210.
      View in: PubMed
    445. Bunn PA. Letter: Should ineffective agents be used in combination chemotherapy? Cancer Chemother Rep. 1974 Mar-Apr; 58(2):127-8. PMID: 4830494.
      View in: PubMed
    446. Bunn P, Schein PS. Letter: Meningeal involvement in lymphoma. N Engl J Med. 1974 Feb 28; 290(9):517. PMID: 4589876.
      View in: PubMed
    447. Bunn PA, Okamoto M, Riker WF. Further observations on subacute denervation and mammalian motor nerve terminal function. Neurology. 1973 Jan; 23(1):12-20. PMID: 4347059.
      View in: PubMed
    448. Bunn PA. Kanamycin. Med Clin North Am. 1970 Sep; 54(5):1245-56. PMID: 4919151.
      View in: PubMed
    449. Bunn PA. Antimicrobial therapy in patients allergic to penicillin. N Y State J Med. 1969 Jul 01; 69(13):1859-65. PMID: 5255289.
      View in: PubMed
    450. Bunn PA. Pneumonia in the older patient. J Am Geriatr Soc. 1968 Jan; 16(1):52-7. PMID: 4294329.
      View in: PubMed
    451. Bunn PA, Lunn JS. Status of kanamycin in therapy of infections. Ann N Y Acad Sci. 1966 Jun 14; 132(2):819-23. PMID: 5227777.
      View in: PubMed
    452. King RB, Stoops WL, Fitzgibbons J, Bunn P. Case reports and technical note. Nocardia asteroides meningitis. A case successfully treated with large doses of sulfadiazine and urea. J Neurosurg. 1966 Apr; 24(4):749-51. PMID: 5934130.
      View in: PubMed
    453. Bunn PA, Lunn J. Antibody responses in serious bacterial diseases: a review. Bol Asoc Med P R. 1966 Feb; 58(2):65-72. PMID: 5326245.
      View in: PubMed
    454. Bunn PA. Present power potions for pestilences and plagues. Trans Am Clin Climatol Assoc. 1966; 77:1-10. PMID: 5885903.
      View in: PubMed
    455. Bunn PA, Wilson JR. Farmer's lung. Introduction. Identification study. N Y State J Med. 1965 Dec 15; 65(24):3013-5. PMID: 4954565.
      View in: PubMed
    456. Lunn JS, Bunn PA. Immunoglobulin responses to bacterial endocarditis. Antimicrob Agents Chemother (Bethesda). 1965; 5:59-63. PMID: 4160678.
      View in: PubMed
    457. Bunn PA, Milicich S, Lunn JS. Pharmacological properties of hetacillin in the human. Antimicrob Agents Chemother (Bethesda). 1965; 5:947-50. PMID: 5883519.
      View in: PubMed
    458. VOYTOVICH A, HEAD JA, BUNN PA, ROHNER RF. SUDDEN DEATH. Minn Med. 1964 Aug; 47:965-74. PMID: 14243341.
      View in: PubMed
    459. Bunn PA, Canarile L, Knight R. Immunologic Distinction among Six Penicillins as Measured by a Hemagglutination Technique: A Preliminary Report with Speculations about their Successive Administration in Humans. Trans Am Clin Climatol Assoc. 1964; 75:153-65. PMID: 21408643.
      View in: PubMed
    460. BUNN PA. ALLERGIC REACTIONS TO PENICILLINS, NEW AND OLD. Antimicrob Agents Chemother (Bethesda). 1964; 10:302-10. PMID: 14287947.
      View in: PubMed
    461. BUNN PA. TREATMENT OF ACUTE BRONCHOPULMONARY INFECTIONS. Adv Cardiopulm Dis. 1964; 22:44-53. PMID: 14284225.
      View in: PubMed
    462. BUNN PA. MANAGEMENT AND ENDOCARDITIS WITH SYNTHETIC PENICILLINS. Antimicrob Agents Chemother (Bethesda). 1964; 10:263-7. PMID: 14287941.
      View in: PubMed
    463. BUNN PA, MILICICH S. LABORATORY AND CLINICAL STUDIES WITH CLOXACILLIN. Antimicrob Agents Chemother (Bethesda). 1963; 161:220-6. PMID: 14274899.
      View in: PubMed
    464. BUNN PA, KNIGHT R. Alteration in chronic staphylococcal furunculosis by use of gamma globulin. N Y State J Med. 1962 Dec 15; 62:3899-907. PMID: 14016850.
      View in: PubMed
    465. BUNN P. Late followup of 64 patients with subacute bacterial endocarditis treated with penicillin. Am J Med Sci. 1962 May; 243:549-57. PMID: 13874669.
      View in: PubMed
    466. BALTCH AL, OSBORNE W, CANARILE L, HASSIRDJIAN A, BUNN PA. Serum properdin, complement and agglutinin changes in dogs with staphylococcal bacteremia. J Immunol. 1962 Mar; 88:361-8. PMID: 13864522.
      View in: PubMed
    467. BUNN PA, AMBERG J. Initial clinical and laboratory experiences with methyl phenyl isoxazolyl penicillin (P-12). N Y State J Med. 1961 Dec 15; 61:4158-62. PMID: 13874670.
      View in: PubMed
    468. BUNN PA. Penicillins. Pediatr Clin North Am. 1961 Nov; 8:981-1000. PMID: 13874672.
      View in: PubMed
    469. BUNN PA. Antibiotics. N Y State J Med. 1961 Oct 15; 61:3426-30. PMID: 13874671.
      View in: PubMed
    470. BALTCH AL, HASSIRDJIAN A, OSBORNE W, BUNN PA. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs. J Lab Clin Med. 1961 Mar; 57:420-7. PMID: 13686461.
      View in: PubMed
    471. BUNN P, KNIGHT R. Problems in determining concentrations of newer penicillins in human serum. Antibiot Chemother (Northfield). 1961 Mar; 11:190-5. PMID: 13688861.
      View in: PubMed
    472. BALTCH AL, OSBORNE W, BUNN PA, CANARILE L, HASSIRDJIAN A. Serum complement and bacteriophage neutralization titers in human infections, leukemias, and lymphomas. J Lab Clin Med. 1960 Oct; 56:594-606. PMID: 13686462.
      View in: PubMed
    473. BUNN PA, KNIGHT R, AMBERG J. Some notes about a new synthetic penicillin for staphylococcal disease. N Y State J Med. 1960 Oct 01; 60:3074-82. PMID: 13688862.
      View in: PubMed
    474. BUNN PA, KNIGHT R. Treatment of pneumococcal pneumonia with a new penicillin: clinical observations in 25 patients. Am J Med Sci. 1960 Aug; 240:192-6. PMID: 13805929.
      View in: PubMed
    475. WRIGHT KW, RENZETTI AD, LUNN J, BUNN PA. Observations on the administration of kanamycin to patients with tuberculosis. Am Rev Tuberc. 1959 Jan; 79(1):72-7. PMID: 13606337.
      View in: PubMed
    476. Bunn PA, Baltch AL. Properdin System in Infections and in Malignant Blood Dyscrasias. Trans Am Clin Climatol Assoc. 1959; 70:55-66. PMID: 21407778.
      View in: PubMed
    477. BUNN PA, BALTCH A. Clinical experiences with kanamycin. N Engl J Med. 1958 Oct 02; 259(14):659-62. PMID: 13590420.
      View in: PubMed
    478. BUNN PA, BALTCH A, KRAJNYAK O. Clinical experiences with kanamycin. Ann N Y Acad Sci. 1958 Sep 30; 76(2):109-21. PMID: 13595498.
      View in: PubMed
    479. WRIGHT KW, RENZETTI AD, LUNN J, BUNN PA. Observations of the use of kanamycin in patients in a tuberculosis hospital. Ann N Y Acad Sci. 1958 Sep 30; 76(2):157-62. PMID: 13595504.
      View in: PubMed
    480. BUNN PA, CRONK GA. [A comparison of blood concentrations following the oral administration of tetracycline hydrochloride, tetracycline phosphate complex, and various tetracycline mixtures]. Antibiotic Med Clin Ther (New York). 1958 Jun; 5(6):379-423. PMID: 13545778.
      View in: PubMed
    481. BUNN P, BALTCH A, OSBORNE W, CANARILI L. Staphylococci: on the ubiquitous nature of human infections and their control by antimicrobial agents, singly or in combination. Ann Intern Med. 1958 Jan; 48(1):102-13. PMID: 13488219.
      View in: PubMed
    482. BUNN P, ROBINSON F. Relative efficacies of chick embryo and standard American Trudeau Society medium in isolation of tubercle bacilli from human sputum. Am Rev Tuberc. 1957 Oct; 76(4):703-5. PMID: 13470321.
      View in: PubMed
    483. BUNN P. Long acting penicillin preparations in infectious diseases. Med Clin North Am. 1957 Mar; 41(2):521-38. PMID: 13407233.
      View in: PubMed
    484. HUBEL KA, PALMERI B, BUNN PA. Tetracycline serum concentrations in man; a study contrasting single capsule doses of tetracycline phosphate complex and tetracycline hydrochloride. Antibiot Annu. 1957-1958; 5:443-6. PMID: 13521840.
      View in: PubMed
    485. BUNN P. Complications in human beings following the use of antibacterial substance. Antibiot Annu. 1957-1958; 5:327-32. PMID: 13521824.
      View in: PubMed
    486. BUNN P. Pyoarthritis: its treatment and the role of adrenal steroids in its pathogenesis. Trans Am Clin Climatol Assoc. 1957-1958; 69:9-19. PMID: 13581083.
      View in: PubMed
    487. BUNN PA. Phenoxymethyl penicillin (V): pharmacologic observations. J Lab Clin Med. 1956 Sep; 48(3):392-8. PMID: 13367576.
      View in: PubMed
    488. RENZETTI AD, WRIGHT KW, EDLING JH, BUNN P. Clinical, bacteriologic, and pharmacologic observations upon cycloserine. Am Rev Tuberc. 1956 Jul; 74(1):128-35. PMID: 13327226.
      View in: PubMed
    489. EASTMAN G, COOK E, BUNN P. Recommended dosage regimens of various antimicrobial agents in management of 25 common infections. N Y State J Med. 1956 Jan 15; 56(2):241-52. PMID: 13280089.
      View in: PubMed
    490. COOK E, EASTMAN G, BUNN P. The use of novobiocin in the management of acute pneumococcal and staphylococcal infections. Antibiot Annu. 1956-1957; 396-401. PMID: 13425411.
      View in: PubMed
    491. BUNN PA, CANARILE L, EASTMAN G. Pharmacologic properties of various antimicrobial agents with particular reference to common dosage scheduling. N Y State J Med. 1955 Dec 15; 55(24):3607-17. PMID: 13272908.
      View in: PubMed
    492. BUNN P. Fundamental considerations in the chemotherapy of acute pneumonias. Am J Surg. 1955 Oct; 90(4):601-10. PMID: 13258954.
      View in: PubMed
    493. BUNN PA, DUTTON R, BERG G, BLACK M. A comparison of therapeutic efficacy between a triple sulfonamide mixture and gantrisin in urinary tract infections. N Y State J Med. 1955 Aug 15; 55(16):2357-60. PMID: 13244865.
      View in: PubMed
    494. BUNN PA, ROBINSON F, OSBORNE W. Use of chick embryo as medium for rapid cultivation of tubercle bacilli. J Lab Clin Med. 1955 Apr; 45(4):658-60. PMID: 14368031.
      View in: PubMed
    495. BUNN PA, COOK ET. Treatment of subacute bacterial endocarditis. Ann Intern Med. 1954 Sep; 41(3):487-500. PMID: 13198003.
      View in: PubMed
    496. BUNN P, ROBINSON F. The use of the rabbit eye as a tissue to study tuberculosis. IV. Effect of therapy with streptomycin-isoniazid and with growth hormone (STH) upon the course of the infection. Am Rev Tuberc. 1954 Jun; 69(6):1016-21. PMID: 13158798.
      View in: PubMed
    497. BUNN P, ROBINSON FO. Effects of decreasing dosages of corticotropin upon the course of ocular tuberculosis in the rabbit. Am Rev Tuberc. 1954 Jun; 69(6):1051-3. PMID: 13158804.
      View in: PubMed
    498. BUNN PA. A report on antibacterial substances. N Y State J Med. 1954 May 01; 54(9):1350-9. PMID: 13154630.
      View in: PubMed
    499. CLARK CW, BUNN PA. Treatment of pylephlebitis secondary to acute appendicitis. N Y State J Med. 1953 Dec 15; 53(24):3007-10. PMID: 13111508.
      View in: PubMed
    500. BUNN PA, COOK E. Treatment of pneumococcal pneumonia with erythromycin and carbomycin (magnamycin). AMA Arch Intern Med. 1953 Sep; 92(3):333-40. PMID: 13091455.
      View in: PubMed
    501. MULLIN EW, WRIGHT KW, BUNN PA. The long-term toxicity and metabolic effects of isoniazid in adults. Am Rev Tuberc. 1953 May; 67(5):652-6. PMID: 13040692.
      View in: PubMed
    502. BUNN PA. Advances in the use of antibacterial substances. Laryngoscope. 1953 Feb; 63(2):128-36. PMID: 13036214.
      View in: PubMed
    503. BUNN PA, ROBINSON F. The use of the rabbit eye to study tuberculosis: the effect of adrenocorticotropin, growth hormone, and a combination of isonicotinic acid hydrazide with streptomycin upon the course of the disease. Trans Annu Meet Natl Tuberc Assoc. 1953; 49:212-3. PMID: 13136321.
      View in: PubMed
    504. BUNN PA. Advances in the use of antibacterial substances. Trans Am Laryngol Rhinol Otol Soc. 1953; 58(57th Meeting):64-72; discussion, 72-4. PMID: 13146748.
      View in: PubMed
    505. BUNN PA. Present trends in the treatment of the pneumonias. N Y State J Med. 1952 Aug 15; 52(16):2005-9. PMID: 13002775.
      View in: PubMed
    506. BUNN P, DROBECK B. Use of rabbit eye as a tissue to study tuberculosis. III. Effect of adrenal hormones upon course of disease and upon certain immunologic responses. Am Rev Tuberc. 1952 Aug; 66(2):175-87. PMID: 14943925.
      View in: PubMed
    507. BUNN P, DROBECK B, GINO J, ADAIR C. Some observations upon the Middlebrook-Dubos hemagglutination test in man and animals. Ann Intern Med. 1952 Jul; 37(1):84-95. PMID: 14933979.
      View in: PubMed
    508. BUNN PA, PEABODY G. Treatment of pneumococcal meningitis with large doses of penicillin; a series of twenty consecutive cases. AMA Arch Intern Med. 1952 May; 89(5):736-42. PMID: 14914213.
      View in: PubMed
    509. BUNN PA. Effect of adrenal hormones upon course of ocular tuberculosis and upon certain immunologic responses in the rabbit. Trans Annu Meet Natl Tuberc Assoc. 1952; 48:406-7. PMID: 13038906.
      View in: PubMed
    510. BUNN PA, DROBECK B. Use of rabbit eye as a tissue to study tuberculosis. I. Development of localized ocular lesion. Am Rev Tuberc. 1951 Aug; 64(2):197-206. PMID: 14847150.
      View in: PubMed
    511. ADAIR CV, DROBECK B, BUNN PA. Use of rabbit eye as a tissue to study tuberculosis. II. Effect of certain antituberculous agents upon ocular tuberculosis. Am Rev Tuberc. 1951 Aug; 64(2):207-17. PMID: 14847151.
      View in: PubMed
    512. ADAIR CV, WOODIN WG, BUNN PA. Clinical and pharmacologic studies with allylmercaptomethyl penicillin (penicillin O). Am J Med. 1951 Aug; 11(2):188-95. PMID: 14856987.
      View in: PubMed
    513. BUNN P, CALDWELL ER, ADAIR C, LEPPER M, DOWLING H. Absorption and clinical use of penicillin preparations given in large oral doses; a cooperative study utilizing discontinuous therapy. J Am Med Assoc. 1950 Dec 30; 144(18):1540-3. PMID: 14794374.
      View in: PubMed
    514. BUNN PA, HAMMOND JD. Chickenpox complicated by severe pneumonia treated with aureomycin. N Y State J Med. 1950 Jun 15; 50(12):1485-7. PMID: 15423720.
      View in: PubMed
    515. BUNN PA. Two-year follow up report of patients with miliary and meningeal tuberculosis treated with streptomycin. Am J Med Sci. 1950 Feb; 219(2):127-32. PMID: 15403157.
      View in: PubMed
    516. BUNN PA. Uses and abuses of penicillin. N Y State J Med. 1949 Sep 01; 49(17):2059-63. PMID: 18148408.
      View in: PubMed
    517. BUNN PA. One hundred cases of miliary and meningeal tuberculosis treated with streptomycin. Am J Med Sci. 1948 Sep; 216(3):286-315. PMID: 18118795.
      View in: PubMed
    518. BUNN PA. Streptomycin in the treatment of human tuberculosis. Dis Chest. 1948 Sep-Oct; 14(5):670-85. PMID: 18885807.
      View in: PubMed
    519. BARNWELL JB, BUNN PA, WALKER AM. [Not Available]. Am Clin. 1948 Jul; 13(1):27-30. PMID: 18869842.
      View in: PubMed
    520. MUSCHENHEIM C, McDERMOTT W, BUNN PA. Streptomycin in clinical tuberculosis. N Y State J Med. 1948 Apr 15; 48(8):889-94. PMID: 18914799.
      View in: PubMed
    521. BUNN PA. Experimental trends in antibiotics. Med Ann Dist Columbia. 1948 Jan; 17(1):1-6. PMID: 18917913.
      View in: PubMed
    522. BUNN PA. Miliary and meningeal tuberculosis treated with streptomycin. J Clin Invest. 1947 Nov; 26(6):1176. PMID: 20340920.
      View in: PubMed
    523. BUNN PA, LABBY DH, et al. Treatment of hepatic insufficiency. N Y State J Med. 1947 May 01; 47(9):1006-15. PMID: 20295034.
      View in: PubMed
    524. MUSCHENHEIM C, BUNN PA, LANSDOWN FS. Observations on tuberculosis control in a university hospital. Ann Intern Med. 1946 Jun; 24:968-87. PMID: 20987274.
      View in: PubMed
    525. McDERMOTT W, BUNN PA, et al. The absorption of orally administered penicillin. Science. 1946 Mar 22; 103(2673):359-61. PMID: 21017955.
      View in: PubMed
    526. McDermott W, Bunn PA, Benoit M, Dubois R, Reynolds ME. The Absorption of Orally Administered Penicillin. Science. 1946 Mar 22; 103(2673):359-61. PMID: 17748223.
      View in: PubMed
    527. McDermott W, Bunn PA, Benoit M, Dubois R, Reynolds ME. THE ABSORPTION, EXCRETION, AND DESTRUCTION OF ORALLY ADMINISTERED PENICILLIN. J Clin Invest. 1946 Mar; 25(2):190-210. PMID: 16695308.
      View in: PubMed
    528. McDERMOTT W, BUNN PA, et al. The absorption, excretion, and destruction of orally administered penicillin. J Clin Invest. 1946 Mar; 25:190-210. PMID: 21025644.
      View in: PubMed
    529. BARR D, BUNN PA, et al. Oral penicillin. N Y State J Med. 1946 Mar 01; 46:527-34. PMID: 21016483.
      View in: PubMed
    530. BUNN PA. Treatment of infections with penicillin given orally. Interne. 1946 Mar; 12:182-8. PMID: 21019086.
      View in: PubMed
    531. McDermott W, Bunn PA, Benoit M, Dubois R, Haynes W. ORAL PENICILLIN. Science. 1945 Mar 02; 101(2618):228-9. PMID: 17814107.
      View in: PubMed
    Bunn's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)